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One indication of increasing fragility of bone is the accumulation of microscopic 
cracks, or microdamage, within the bone matrix.  Microdamage accumulates in bone of 
the elderly, when changes in bone material properties and matrix architecture coupled 
with a decrease in bone repair mechanisms compromise bone integrity.  Although men 
experience loss of bone mass with age, osteopenic changes in women occur at an earlier 
age and accelerate when estrogen’s bone-protective effects diminish after menopause.  
Consequently, 3 out of 4 fragility fractures occur in women.  To preserve bone mass and 
reduce fracture risk, therapeutics which alter the morphology of bone are prescribed to at-
risk patients.  The most commonly prescribed drug to prevent osteoporotic bone fracture 
is alendronate, a bisphosphonate which increases bone volume fraction by decreasing the 
rate of bone turnover.  However, concerns over adverse effects of prolonged turnover 
suppression have been reinforced by findings of increased microdamage density with 
alendronate use.   
Microdamage formation is not always pathologic, but extensive accumulation of 
damage can be an indicator of reduced bone quality.  The work in this thesis explores the 
hypothesis that microdamage in bone of lower quality will form more easily and progress 
more extensively than in bone of higher quality.  The effects of aging, sex, and 
alendronate treatment on microdamage initiation of linear, diffuse, and severe 
morphologies were investigated in trabecular bone.  With the use of micro-computed 
tomography at high resolution, estimations of the stress/strain environment of individual 
trabeculae within the trabecular lattice were obtained with finite element modeling.  
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Calcium-chelating fluorophores were used to fluorescently label damage in bone, and 
stress and strain values of trabeculae were linked to observed damage morphologies 
resulting from mechanical loading.  Across all studies, microdamage morphology was 
highly associated with the stress/strain magnitude on damaged trabeculae.  Furthermore, 
thinner, rod-like trabeculae oriented along the loading axis were most likely to develop 
severe damage in all studies.   
Microdamage initiation stresses and strains were obtained for trabecular bone 
from older females, older males, and younger females to determine whether thresholds 
for damage initiation were lower in older females.  Results suggest that the stress 
threshold for damage initiation in older females may indeed be lower compared with 
younger females, and that normalized strain thresholds for severe damage formation in 
older males may be decreased compared with older females.  Damage propagation was 
evaluated as a function of age and sex to determine whether damage in older women 
progressed more extensively than in younger women or men.  Results suggest that bone 
from older individuals had decreased resistance to crack propagation evidenced by an 
increased number of severely damaged trabeculae which extended in area under cyclic 
loading; however no sex differences were uncovered.  Finally, the stress/strain thresholds 
for damage initiation were investigated in alendronate-treated bone, and results indicate 
that a decreased stress threshold was needed to initiate damage formation of a linear and 
severe morphology after one year of treatment.  After three years of treatment, however, 
micromechanical properties recovered, perhaps due to increased matrix mineralization 







Decreased bone mass in aging individuals is a well-established risk factor for 
osteoporotic fracture.  However, loss of bone mass alone cannot account for increased 
age-related fracture risk, for at a given bone mass, fracture risk is still significantly 
greater in older individuals than younger individuals. (Hui et al. 1988)  It has been 
proposed that factors related to bone quality are as important as bone density in 
predicting the risk of fractures. (McCreadie et al. 2000)  Bone quality is an imprecise 
term used to refer to factors other than bone mineral density that influence bone’s 
biomechanical properties.  These factors include alterations in extracellular matrix 
heterogeneity and composition (e.g. collagen and noncollagenous proteins, mineral, and 
water content), microarchitecture (e.g. trabecular thickness, degree of anisotropy, and 
structure model index), and remodeling rate. (Hildebrand et al. 1999; Paschalis et al. 
2004; Recker et al. 2004; Busse et al. 2009)  Accumulation and propagation of 
microdamage within the bone matrix can also be an indication of increasing fragility, as 
extensive damage is associated with loss of stiffness and strength. (Schaffler et al. 1989; 
Burr et al. 1997; Yeh et al. 2001)   
Many studies have reported significant increases in microdamage density with 
age. (Mori et al. 1993; Schaffler et al. 1995; Mori et al. 1997; Norman et al. 1998; 
Fazzalari et al. 2002; Seeman 2003)  While age-related changes in bone structure and 
composition play a substantial role in promoting microdamage formation, there is also a 
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breakdown in the microdamage-remodeling feedback loop in aging: the targeted removal 
and repair of damaged regions is reduced even as the rate of stochastic bone remodeling 
is increased. (Allen 2008)  This results in a structure with decreased bone mass and an 
increased number of damaged regions.  When loss of bone mass reaches a critical level, 
osteoporosis is diagnosed.   
Many therapies are used currently to combat the loss of bone mass, and they can 
be divided into two broad categories based on whether they stimulate bone formation 
(teriparatide) or whether they reduce bone resorption (bisphosphonates, selective estrogen 
receptor modulators, denosumab, strontium ranelate). (Reginster 2011)  Of these, 
bisphosphonates are most commonly prescribed for osteoporosis prevention and 
treatment.  Bisphosphonates’ specific action is on osteoclasts, where they inhibit 
osteoclast recruitment and adhesion, shorten the lifespan of osteoclasts, and inhibit 
osteoclastic bone resorption. (Fleisch 1998)  Their efficacy in fracture prevention has 
been demonstrated, particularly in sites with large amounts of trabecular bone like the 
wrist, hip, and vertebrae. (Black et al. 1996; Black et al. 2000)  However, concerns about 
long-term consequences of bone turnover suppression have been corroborated by reports 
of increased microdamage density with treatment. (Allen et al. 2006; Stepan et al. 2007)  
Additionally, clinically apparent atypical femoral fractures have been associated with 
bisphosphonate use, for which microdamage accumulation may play a role. (Shane et al. 
2010) 
Despite the association of microdamage with adverse biomechanical effects, 
damage formation is not always pathologic.  Studies have shown that crack growth in 
bone is stable due to the formation of a plastic zone at the crack tip. (Vashishth et al. 
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1997)    This mechanism increases the toughness of bone by allowing for the absorption 
and dissipation of energy that may otherwise, in more brittle materials, lead to crack 
extension. (Norman et al. 1995; Vashishth et al. 1997; Zioupos 2001)  However it is clear 
that, if left unrepaired, microdamage accumulation imposes significant adverse effects on 
the mechanical properties of bone. (Schaffler et al. 1995; Hoshaw et al. 1997; Zioupos 
2001; Wang et al. 2004)  Moreover, in another study, appreciable damage accumulation 
was not apparent until bone had lost 15% of its elastic modulus, suggesting that damage 
accumulation can be an indicator of reduced mechanical properties. (Burr et al. 1998)  In 
order to assess the significance of microdamage in skeletal fragility and traumatic 
fractures, its mechanisms must be elucidated on a tissue-level scale where the interactions 
of bone matrix properties, the local biomechanical environment, and trabecular 
architecture are concurrently examined for their contributions to microdamage formation.  
The goal of this work was to demonstrate that changes in bone quality due to 
aging, sex, and bisphosphonate treatment are reflected in differences in the mechanics of 
microdamage initiation and propagation in trabecular bone.  The central hypothesis of 
this thesis is that microdamage in bone of lower quality will form at decreased 
stress/strain levels and progress more extensively than in bone of higher quality.   
1.2 Specific Aims 
This hypothesis is tested in three specific aims: 
I. Evaluate Factors Promoting Microdamage Initiation of Different Morphological 
Types in Human Trabecular Bone as a Function of Age and Gender 
Fragility fracture rates are at their highest levels in older women when the bone-
protective effects of estrogen diminish after menopause.  Estrogen protects bone mass by 
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inhibiting osteoclastic bone resorption. (Kameda et al. 1997)  As the concentration of 
estrogen falls after menopause, the number of remodeling sites and extent of bone 
resorption in basic multicellular units increases. (Seeman 2003)  This results in fewer and 
thinner trabeculae, which reduces the strength and stiffness of the structure.  Work 
conducted in this aim investigates whether these changes in trabecular bone lead to a 
decreased stress/strain threshold for microdamage initiation.  The hypothesis is that the 
stress threshold for microdamage initiation will be lower in trabecular bone from older 
females compared to younger females and older males.   
II. Determine the Factors Promoting Microdamage Propagation in Human 
Trabecular Bone as a Function of Age and Gender 
Microdamage density has been shown to increase with age in trabecular bone and 
is associated with decreased fracture toughness. (Schaffler et al. 1995; Zioupos 2001)  
Repetitive loading on microdamaged structures can further advance the extent of damage, 
decreasing stiffness and increasing the risk of overt fracture.  (Diab et al. 2005)  
Extensive studies of crack propagation in cortical bone have been conducted, (Schaffler 
et al. 1995; Vashishth et al. 1997; Norman et al. 1998; Vashishth et al. 2000; Zioupos 
2001; Zioupos 2001) but data in trabecular bone is lacking. (Seeman 2003; Cook et al. 
2009)  The goal of this aim is to determine whether age and gender-related changes in 
bone quality lead to increased microdamage propagation in older females.  The 
hypothesis is that microdamage propagation in trabecular bone due to increasing age and 
female gender will show decreased resistance to microdamage propagation than in 
younger subjects and men.   
III. Determine the Effects of Alendronate Administration on Microdamage 
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Initiation in Canine Trabecular Bone as a Function of Damage Severity, 
Bisphosphonate Dose, and Treatment Duration 
Alendronate is a commonly prescribed therapeutic used to prevent fracture in 
areas of the skeleton with a large proportion of trabecular bone by reducing bone 
remodeling, thereby increasing bone mass.  Its clinical efficacy in fracture prevention has 
been well documented. (Black et al. 1996; Black et al. 2000)  However, concerns over 
adverse effects of prolonged turnover suppression have been reinforced by findings of 
increased microdamage density with alendronate use. (Allen et al. 2006; Stepan et al. 
2007)  In this aim, the effect of alendronate administration on microdamage initiation is 
investigated in an animal model after 1 and 3 years of treatment at two clinically relevant 
doses corresponding to an osteoporotic treatment dose and a Paget’s disease treatment 
dose. The hypothesis is that changes in bone quality will be demonstrated by a decreased 
stress/strain associated with microdamage initiation after one year of treatment, but that 
further alterations in bone quality will not be observed with increased treatment duration 
and dose. 
1.3 Significance 
Fragility fractures are a significant public health concern: in the US, it is 
estimated that 40% of white women and 13% of white men over 50 will experience a 
clinically apparent fragility fracture. (Cummings 2002)   Fractures also cause significant 
morbidity associated with chronic pain, reduced mobility, disability, and an increased 
degree of dependence on others. (Keene et al. 1993)  The risk of death related to hip 
fracture is 2.8%, equivalent to the risk of death from breast cancer in women. (Cummings 
1989)  These statistics illustrate the great need for research into the mechanisms of bone 
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fragility fracture.   
The work presented in this thesis is significant because it investigates the impact 
of age, sex, and alendronate use on the mechanics of microdamage formation and 
progression in trabecular bone, three factors which are of particular relevance due to 
positive associations between damage accumulation and fracture.  Since microdamage 
accumulation has an important effect on bone structural properties like stiffness, strength, 
and toughness (Schaffler et al. 1995; Hoshaw et al. 1997; Zioupos 2001), an investigation 
into the factors affecting microdamage initiation and propagation are important in 
determining the role damage accumulation plays in skeletal fragility and fracture.  
The methods detailed in the following chapters are innovative in their integration 
of histology, high resolution micro-computed tomography, and image-based finite 
element modeling.  Furthermore, the novelty of solving for trabecular stresses and strains 
associated with different damage morphologies contributes greatly to the current 
understanding of factors influencing microdamage formation.  Finally, by advancing 
knowledge in the field by building upon the work of others, results will complement 















BACKGROUND AND LITERATURE REVIEW 
 
 
2.1 Bone Function and Structural Hierarchy 
2.1.1 Bone Structure at the Apparent Level 
 
 Bones can vary widely in form: long bones (ex. femur, humerus) are cylindrical, 
while short and sesamoid bones (ex. carpels of the hand, patella) are more cuboid.  Flat 
bones (ex. skull, sternum) are flat, while irregular bones don’t fit into any of these 
categories and vary widely in shape (ex. vertebrae, sacrum).   Each of these types also 
varies in their tissue organization depending on their function.  Spongy tissue called 
trabecular (or cancellous) bone is found in the ends of long bones and within flat and 
irregular bones where material deformation allows for elastic energy dissipation.  Dense 
cortical (or compact) bone is found throughout the skeleton, imparting strength and 
protection to internal organs.   
2.1.2 Bone Structure at the Microstructural Level 
The most striking difference between cortical and trabecular bone is in porosity – 
cortical bone is dense with porosity less than 5%, whereas trabecular bone is much less 
so, often described as a honeycomb-like structure composed of trabecular struts in the 
shape of plates or rods with porosity ranging between 50-90% (Figure 2.1).  Overall, 80% 
of bony tissue in the adult human body is cortical and the remaining 20% is trabecular.  
(Clarke 2008)   Cortical and cancellous bone can be further divided into woven and 
lamellar bone.  Woven bone is immature bone formed during growth or healing of bone 
structures.  It is replaced by mature lamellar bone which is more organized and 
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mineralized than woven bone.   
 
 
Figure 2.1.  Structural Organization of Bone.  Cortical bone is shown to envelope 
trabecular bone, a common distribution found in long bones and vertebral bodies.  
 
 
The functional unit of cortical bone is the osteon, also called a Haversian system.  
The osteon is a cylindrical structure roughly 100 to 300 µm in diameter, the long axis of 
which is aligned parallel with the major axis of stress.  It is created from thin sheets of 
lamellae which run concentrically around a central cavity (the Haversian canal) where 
blood vessels and nerves are housed.  Cement lines are formed at the periphery of each 
osteon, and interstitial bone is created from lamellar fragments between intact osteons.  
Osteons are connected through Volkmann’s canals containing blood vessels which run 
transversely between different Haversian systems.   
The functional unit of trabecular bone is known as the hemiosteon, or trabecular 
packet (approximately 50 µm in thickness), which is organized similarly to the osteon but 
does not contain vascular channels.  Lamellae in the hemiosteon are arranged 
longitudinally along the trabeculae, rather than concentrically as observed in compact 
U.S. National Cancer Institute's Surveillance, Epidemiology 
 and End Results (SEER) Program 
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bone osteons.  As in cortical bone, interstitial bone is created from disorganized lamellae 
between hemiosteons.  Lacunae, small cavities housing trapped bone cells called 
osteocytes, are found in both cortical and trabecular bone.   
2.1.3 Bone Structure at the Ultrastructural Level 
At the nanoscale, cortical and trabecular bone are identical.  Bone is a complex 
material, comprised of both organic matrix and crystalline salts.  The organic matrix of 
bone is 90 to 95% collagen fibrils which extend along the lines of tensional force, 
providing much of bone’s tensile strength.  The remaining organic material is what is 
termed “ground substance,” which includes chondroitin sulfate and hyaluronic acid.  
These compounds are thought to aid in the deposition of calcium salts.  The major 
crystalline salt found in bone is hydroxyapatite, formed from calcium and phosphate.  
This material gives bone great compression strength.  The organic matrix and crystalline 
mineral interact intimately; collagen fibrils lie adjacent to hydroxyapatite crystals and 
bind tightly to it.  This prevents shearing due to crystals and collagen slipping out of 
place.  Additionally, adjacent collagen fibrils overlap one another, creating overlapping 
hydroxyapatite crystals which increase the stability of the structure.  Thus, bone material 
is able to demonstrate great tensile as well as compressive strength (Guyton & Hall, 
2006). 
2.1.4 Bone Function 
 Bone serves as the structural foundation of the human body, allowing for muscle 
attachment, organ and nerve protection, and storage of key physiological ions such as 
calcium and phosphate.  Additionally, bones harbor bone marrow containing vital 
components of the hematopoietic system like platelets and red and white blood cells.   
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 Bone’s material composition accounts for much of its base strength; however, 
differences in organization between cortical and trabecular bone at the micro-scale result 
in vastly different mechanical properties.  Bone strength is highly dependent on porosity.  
Its strength, however, is limited by its functional requirements as well.  Bone must be 
dense enough to withstand normal forces, but not so dense as to impede movement or add 
weight beyond which can be supported by muscle.  Bone must also provide rigidity when 
stressed but act as shock absorbers to withstand repetitive forces.  This dual requirement 
is matched physiologically: the low porosity of cortical bone provides strength in long 
bone diaphyses, while porous, interconnected trabecular bone accommodates energy 
absorption in metaphyseal regions and vertebral bodies.  Trabeculae are aligned 
according to stress patterns, but are reinforced by transversely oriented trabeculae to 
withstand minor assaults in other planes.  Thus trabeculae are highly interconnected.  
Finally, a precise combination of organic and inorganic material provides bone’s baseline 
material strength; imbalance of these components can result in brittle, stiff bones as seen 
in osteoporosis, or flexible, weak bones seen in osteomalacia. (Turner 2002)  The balance 
achieved between structure and function provides bone with extraordinary capacity to 
balance sometimes contradictory requirements. 
2.2 Cellular Components of Bone 
Bone has the important ability to tailor its structure to the loading environment 
and repair small cracks or fractures.  This ability is garnered from cells which live in and 
around bone tissue.  There are three main types of bone cells: osteocytes, osteoclasts, and 
osteoblasts. Osteoblasts are cells that synthesize all constituents of the unmineralized 
bone matrix, including collageneous and non-collagenous proteins.  Osteoclasts are 
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multinucleated cells which are formed by the fusion of mononuclear progenitors and are 
responsible for bone resorption.  Osteocytes possess long cytoplasmic processes which 
extend through a canalicular system to adjacent cells, allowing for rapid communication 
by exchanging ions and signaling molecules through gap junctions.  Because of this 
elaborate organization, osteocytes are well placed to sense changes in strain and respond 
to tissue microdamage. 
2.2.1 The Bone Remodeling Process   
 Bone remodeling is a complex process involving coordination between 
osteoclastic bone resorption and osteoblastic bone formation.  It is initiated in response to 
a variety of conditions, including regulation of mineral concentration, adaptation to 
changing mechanical environments, and repair of microdamage.  Bone remodeling can be 
targeted towards specific sites, in the case of mechanical adaptation and damage repair, 
or may be initiated in a non-targeted manner for mineral regulation. (Burr 2002)  As 
much as 30% of bone remodeling may be a result of targeted repair.  (Mashiba et al. 
2001; Burr 2002)   
 The bone remodeling process can be understood as a series of progressive stages 
involving multiple cells within a bone multicellular unit (BMU) coupled by space and 
time.  Osteoclasts within the BMU reabsorb old or damaged bone, a process that takes 
approximately 3 weeks per site. Osteoblasts then rebuild bone at the site, which takes 
about 3 to 4 months. (Rodan et al. 2000)  There are five stages of the remodeling process: 
resting, activation, resorption, reversal, and formation.  (Hill 1998) 
 In the resting stage, osteoprogenitor cells line the surface of bone until activation 
in response to chemical factors.  About 80% of cancellous and cortical bone surfaces, and 
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95% of intracortical surfaces, are inactive at any given time.  (Hill 1998)  When 
stimulated, the activation phase begins as osteoclast progenitors differentiate into 
osteoclasts and attach to the bone surface. 
 Bone remodeling begins with the osteoclast, which moves to the site to be 
resorbed, attaches to the bone surface, and forms a ruffled border across which acidic and 
protease compounds are pumped.  Hydrochloric acid is released first, which is effective 
at dissolving the mineralized components of the matrix. Proteases like cathepsin K and 
other metalloproteases then digest the organic collagen and other proteins. The 
osteoclasts then endocytose and digest the degradation products.   (Teitelbaum 2000)  
The cavity that is formed from removal of tissue is called a Howship’s lacuna.  
Osteoclasts then return to a quiescent form or undergo apoptosis.  (Schindeler et al. 2008) 
 The reversal phase follows which lasts approximately 9 days where osteoclasts 
disappear and macrophage-like cells are seen on the bone surface, perhaps contributing to 
the stimulation of osteoblasts and also removing debris from the resorption process. (Hill 
1998)  Once the area has been cleared of degradation products, osteoblasts move in to 
regenerate the bone matrix.  This begins the formation phase. 
 Osteoblasts move into the resorption pit and begin to lay osteoid, an 
undermineralized bone matrix scaffold upon which minerals deposit as the matrix 
matures.  Osteoid reaches approximately 70% of its final mineralization after 5 to 10 
days, and takes up to 350 days to fully mature. (Fuchs et al. 2008)  A period of secondary 
mineralization follows, which is completed after 30 months. (Bala et al. 2010)  The 
amount of bone removed by osteoclasts compared to the amount regenerated by 
osteoblasts is referred to as the bone balance.  With aging, a net negative bone balance is 
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seen as more bone is resorbed by osteoclasts than replaced by osteoblasts in the BMU.  
 Since the behavior of osteoblasts and osteoclasts is coordinated within a 
resorption pit, remodeling is described as being coupled.  Coupling is controlled through 
paracrine signals secreted by osteoblasts which regulate the differentiation and activation 
of osteoclasts.  In the resting phase, osteoclasts are kept inactive by osteoprotegerin 
(OPG), a tumor necrosis factor receptor which is secreted by osteoblastic stromal cells.  
OPG binds to RANKL (receptor for activator of nuclear factor-κβ ligand, also secreted 
by osteoblasts) and prevents it from binding to its receptor RANK (receptor for activator 
of nuclear factor-κβ) on osteoclastic progenitor cells, which is required for osteoclastic 
stimulation.  Osteoblastic stromal cells then control bone resorption by increasing the 
expression of RANKL and decreasing the expression of OPG. (Robling et al. 2006) 
2.2.2 Aging, Remodeling, and Osteoporosis 
 The rate of bone remodeling increases in late mid-life as the concentration of sex 
hormones declines. (Khosla et al. 1998; Riggs et al. 1998; Recker et al. 2004)  One would 
expect that the increased rate of bone turnover would mean that microdamage density 
was low, but this is not the case.  It is well documented that microdamage accumulates 
with age, suggesting that targeted remodeling repair mechanisms are compromised with 
aging even as stochastic remodeling is ramped up. (Schaffler et al. 1995; Allen 2008) 
This may result if signaling mechanisms are compromised, which is plausible considering 
that osteocyte numbers also decline with age. (Mori et al. 1997; Vashishth et al. 2000)  
Low bone mineral density has also been shown to be a factor in microdamage formation, 
and it is possible that repair mechanisms cannot keep up with increased damage 
formation.  (Stepan et al. 2007)  This increased rate of remodeling may be the most 
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significant factor in predicting fracture risk, even more so than bone mineral density 
values. (Cummings 2002; Heaney 2003; Recker et al. 2004)  Remodeling can produce 
transient weakness because, not only does the removal of old bony material locally 
weaken bone, but also new osteoid is less stiff than mature matrix. (Recker et al. 2004) 
 When bone mineral density declines to a point that is 2.5 standard deviations 
lower than the average peak bone mass for a woman at age 30, osteoporosis is diagnosed.  
This disease is associated with an increased risk of fracture, especially in areas with high 
amounts of trabecular bone like the hip, wrist, and spine.  It occurs due to an increase in 
remodeling rates coupled with a negative bone balance at the BMU.  (Compston 2002)  
There are some who suggest that osteoporosis is at the extreme of a continuous spectrum 
of increased remodeling rates and bone loss that occurs normally with aging and does not 
have a separate mechanism itself.  (Keaveny et al. 2002)  Currently, no causative agent 
has been identified that distinguishes the mechanism for osteoporosis development 
(excluding drug-induced forms) from age-related bone loss mechanisms.  
2.2.3 Drugs which Modulate the Bone Remodeling Process 
 A variety of therapies exist which target cells within the bone remodeling process 
to modulate the rate and amount of bone formation.  Generally, they can be divided into 
two groups: stimulators of bone formation and inhibitors of bone resorption. 
2.2.3.1 Stimulators of Bone Formation 
 In some instances, the loss of bone mass is so great that slowing bone resorption 
is not enough – new bone formation must also be stimulated.  For these cases, drugs 
which target the osteoblast are prescribed.  Parathyroid hormone (PTH) and its 
recombinant form, teriparatide, stimulate bone formation by increasing the number and 
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activity of osteoblasts. (Dobnig et al. 1995)  Intermittent dosing of PTH has been shown 
to increase vertebral and femoral neck bone density. (Dobnig et al. 1995; Lane et al. 
1998)  There is also evidence that treatment with teriparatide reduces microdamage 
accumulation in the iliac crest of patients previously treated with alendronate. (Dobnig et 
al. 2009) 
 Strontium ranelate is a new drug that has been shown to reduce the risk of 
vertebral and nonvertebral fractures in women with post-menopausal osteoporosis. 
(Meunier et al. 2004; Reginster et al. 2005; Roux et al. 2006)  Its mechanism of action is 
still under investigation; while some have shown anabolic effects of bone formation, 
(Reginster et al. 2005; Caverzasio 2008) others have not. (Fuchs et al. 2008; Ma et al. 
2011) 
2.2.3.2 Inhibitors of Bone Resorption 
 Many bone diseases are caused by an increase in the rate and/or amount of bone 
reabsorbed by osteoclasts.  For these diseases, drugs which slow the bone resorption 
phase of bone remodeling equalize the balance between resorption and formation and 
stabilize bone mass.  The cellular target is the osteoclast, and these drugs work either by 
preventing their differentiation from precursors or inducing apoptosis of the cells directly.  
 Estrogens and selective estrogen receptor modulators (SERMs) work through this 
first mechanism, inhibiting osteoclastic differentiation.  Raloxifene, a commonly used 
drug within the class of SERMs, has been shown to reduce the risk of vertebral fracture 
by 40%, despite increasing bone density by only 3 to 4%. (Delmas et al. 1997; Cummings 
et al. 1999; Ettinger et al. 1999)  Bisphosphonates work through the second mechanism, 
inducing apoptosis of osteoclasts. 
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2.2.3.3 Bisphosphonates 
 Bisphosphonates are pyrophosphate analogs, containing a phosphate-carbon-
phosphate (P-C-P) backbone that gives them affinity for bone and renders them resistant 
to enzymatic degradation. (Grey et al. 2006)  Of all therapeutics available, they are the 
most effective inhibitors of bone resorption, achieving this result by inhibiting the 
enzyme farnesyl diphosphate synthase in the mevalonate pathway of cholesterol synthesis 
within the osteoclast. (Luckman et al. 1998; Fisher et al. 1999)  This induces osteoclasts 
to undergo programmed cell death (apotose), resulting in reduced bone resorption, lower 
bone turnover, and a positive bone balance. (Rodan et al. 2000)  Side chains added to the 
P-C-P backbone modulate the characteristics of the bisphosphonate and have generated a 
large number of therapeutics. (Figure 2.2)  The addition of nitrogen in the alkyl chain 
increases the antiresorptive potency of the drugs from between 100 to 10000x that of 
non-nitrogen containing bisphosphonates. (Russell et al. 1999) 
 
 
   
Figure 2.2 Chemical Structures of Some Commonly Prescribed Bisphosphonates 
(Rodan et al. 2000) In order of increasing potency: alendronate (Fosamax), risedronate 
(Actonel), ibandronate (Boniva), and zoledronate (Reclast).  
 
 
 Alendronate was the first inhibitor of bone resorption to show a significant 
reduction in the number of fractures of the spine, wrist, and hip. (Liberman et al. 1995; 
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Black et al. 1996)  Alendronate has been shown to increase bone density in the vertebrae, 
femoral neck and trochanter, iliac crest, and wrist.  (Black et al. 1996; Seeman 1999; 
Recker et al. 2005)  It also improves bone microarchitecture by increasing trabecular 
thickness, decreasing trabecular spacing, and decreasing anisotropy. (Hu et al. 2002; 
Recker et al. 2005)  Investigations of its effects on bone composition reveal increased 
degree and uniformity of bone matrix mineralization and increased collagen crosslinking, 
all of which can increase strength and stiffness of bone.  (Roschger et al. 2001)  These 
changes account for its effectiveness in reducing the risk of bone fracture. 
 While alendronate’s efficacy in reducing fractures is well proven, it is also 
associated with a number of side effects.  Two side effects in particular, osteonecrosis of 
the jaw and atypical femoral subtrochanteric fractures, are thought to occur due to an 
oversuppression of bone turnover, which increases the brittleness of the bone material.  
(Goh et al. 2007; Wynn 2007; Neviaser et al. 2008; Bocanegra-Perez et al. 2009)  While 
these side effects cause substantial morbidity, they are rare: a recent study in Danish 
women reported 100 atypical subtrochanteric fractures per 100,000 patients on long-term 
alendronate treatment (Abrahamsen et al. 2009) and less than one incident of 
osteonecrosis of the jaw per 14,200 patient treatment-years. (Grbic et al. 2010) However, 
the use of bisphosphonates in diseases like cancer has shown an increased risk for these 
side effects.  (Bamias et al. 2005)  
 Another sub-clinical side effect of bisphosphonate use is the accumulation of 
microdamage. (Allen et al. 2006; Stepan et al. 2007)  The link between bisphosphonate 
use and microdamage accumulation is discussed in more depth in section 2.4.1. 
2.3 Trabecular Bone Mechanical Properties 
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The mechanical properties of trabecular bone can be examined at the structural 
level with trabecular bone samples large enough for continuum assumptions to be valid 
(no smaller than 3 to 5 intertrabecular lengths), or can be determined at the tissue level 
for individual trabeculae. (Harrigan et al. 1988) Accurately defining properties like tissue 
and apparent-level stiffness, ultimate strength, and toughness are important to the work 
developed in this thesis because finite element models in particular rely on the input of 
properties which dictate how a material will behave under loading.  Furthermore, in order 
to fully appreciate the consequences of how aging and bisphosphonate use affect bone 
fragility, one must have a basic understanding of the mechanical properties of healthy 
tissue.   
2.3.1 Apparent and Tissue-Level Strength and Stiffness of Trabecular Bone 
 Trabecular bone is viscoelastic and exhibits properties of a transversely isotropic 
cellular solid in healthy young adults. (Linde et al. 1990; Linde 1994)  Its viscoelasticity 
results from its organization as a composite, consisting of an inorganic mineral phase and 
an organic (mostly) collagenous phase.  Bone has asymmetric tissue properties, 
exhibiting greater strength in compression than in tension.  (Keaveny et al. 1997; Niebur 
et al. 2000)  Trabecular bone strength in standard specimens has been reported between 
2.4 and 5.8 MPa. (Linde et al. 1992)  Stiffness values for trabecular bone structure have 
been reported between 78 to over 1000 MPa, though typical values are closer to the upper 
portion of this range. (Linde et al. 1992)   
 The typical stress/strain curve of trabecular bone in uniaxial loading is similar to 
that of a ductile metal, with an initial linear elastic region up to a strain yield ranging 
from 0.7 to 1.4% (Linde 1994), followed by non-linear plastic deformation with 
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substantial post-yield behavior.  Early studies conducted in trabecular bone detected a 
non-linear ‘toe-in’ region, but work by Keaveny et al demonstrated that this region was 
erroneous, reflecting end-effects rather than true tissue behavior. (Keaveny et al. 1997)  
Beyond yield, there is a non-linear increase in stress until the ultimate stress is reached.  
Further increases in strain beyond the failure point results in a stress plateau as trabeculae 
are fractured up until all pores are filled with fractured bone and stresses again increase.  
This point occurs after 30-70% strain depending on the porosity of the trabecular 
structure.  (Hayes et al. 1976)    
The mechanical properties of the trabecular bone structure vary widely among 
individuals and between anatomical sites.  While differences in bone volume fraction 
have a large effect on the variability of trabecular bone mechanical properties, accounting 
for up to 83% of the variability in the vertebrae and 92% of the variability in the proximal 
femur, other factors such as trabecular architectural organization and bone material 
composition also affect the mechanical response.  (McCalden et al. 1997; Morgan et al. 
2001; Keaveny et al. 2002)  Alterations in trabecular orientation and anisotropy have also 
been shown to influence variability in stiffness measures, especially in multi-axial 
testing. (Hodgskinson et al. 1990; Goulet et al. 1994)  Additionally, the degree of 
mineralization and collagen cross-linking affects not only stiffness, but also non-linear 
properties of bone as well. (Currey 1984; Wang et al. 2002)  Though studies vary widely 
in their reports of trabecular bone strength and elastic modulus, it is generally accepted 
that the stiffness of trabecular bone is 20 to 30% less than that of cortical bone. (Kuhn et 
al. 1989; Choi et al. 1992)   
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 While trabecular bone shows a wide distribution in strength, yield strains remain 
fairly constant.  Studies have shown that they vary little with differences in density and 
are isotropic. (Turner 1989; Keaveny et al. 1994)  Yield strains are higher in compression 
than tension and are similar within anatomic sites but can vary between sites.  
(Kopperdahl et al. 1998; Morgan et al. 2001)  This implies that, if the elastic properties of 
samples are known, then strength can be estimated based on yield strains. (Keaveny 
2001) 
 Tissue-level properties are more difficult to determine, and values have been 
reported using a variety of direct measurement tools, from micro/nano-indentation to 
bending and uniaxial tension/compression tests of individual, machined trabeculae.  
These direct measurement studies estimate tissue stiffness to be from 1 GPa obtained 
from tensile testing to 13-15 GPa via ultrasonic technique, with bending and compression 
test results reporting values in between this range. (Kuhn et al. 1989; Ryan et al. 1989; 
Rho et al. 1993)  However, these measurements are prone to error due to their small size. 
2.3.2 The Back-Calculation Method for Determination of Tissue-Level Stiffness  
 An indirect way of determining tissue-level stiffness is to use a back-calculation 
method. (van Rietbergen B 1995)  In this method, trabecular bone samples (spanning at 
least 3-5 trabecular lengths for continuum assumptions) are scanned with micro-CT and 
reconstructed into a 3D image. (Harrigan et al. 1988) The 3D reconstructed image is 
directly converted into a large-scale finite element model, and the model is solved using 
an initial guess for the tissue modulus and boundary conditions simulating uniaxial 
compression.  This will give a computational estimation of the apparent elastic modulus.  
Uniaxial compression testing of trabecular bone samples are also conducted to obtain 
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values for the apparent elastic modulus.  Under assumptions of linear elasticity, the true 
tissue modulus can be solved for as the ratio between the apparent modulus obtained in 













where E(FEM)tissue is equal to the initial guess for tissue modulus input into the finite 
element model.  One study using this technique reported an r2 value of 0.89 between the 
experimentally measured and calculated tissue modulus.  (Hou et al. 1998)  
2.3.3 Fatigue Behavior of Bone  
 Fatigue testing of bone is generally carried out at supraphysiological strains 
because failure can require over tens of millions of loading cycles at physiological strain 
levels and rates. (Schaffler et al. 1990)  The endurance limit of cortical bone has been 
estimated at a normalized stress of 0.4%, (Moore et al. 2003) and the changes in stiffness 
and strength that occur during fatigue testing above this limit has been attributed to 
microdamage accumulation. (Moore et al. 2003) Creep has been shown to have a 
marginal impact on fatigue behavior at low stress levels. (Carter et al. 1976; Moore et al. 
2004)  In compressive fatigue testing, appreciable decreases in modulus occur in the later 
half of fatigue life; in tensile fatigue testing, however, there is an early, rapid decrease in 
modulus followed by a plateau before the rapid loss of modulus to failure.  (Pattin et al. 
1996)  Trabecular bone also has a shorter fatigue life in tension than in compression. 
(Caler et al. 1989)  However, fatigue properties in vivo are likely different from those 
determined in vitro due to the viscoelasticity of bone and the strain rate-dependence of 
fatigue life. (Donahue et al. 2006) 
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2.3.4 Fracture Toughness of Bone 
 Bone is a highly organized heterogeneous structure, composed of minerals and 
proteins organized into osteons and hemiosteons.  This organization contributes greatly to 
the fracture toughness of bone.  In a study in cortical bone by Nalla et al, it was shown 
that uncracked ligament bridging is an extrinsic toughening mechanism found in in-plane 
longitudinal cracks to bridge cracks upon opening.  Collagen fibrils also contribute to 
crack-bridging in anti-plane longitudinal directions.  The osteonal organization plays an 
important role in fracture toughening as well; osteonal cement lines can provide a weak 
path for crack propagation, which promotes deflected out-of-plane crack growth rather 
than growth through osteons.  This mechanism contributes greatly to fracture toughness, 
as the stress intensity is reduced approximately 50% compared to an undeflected crack. 
(Nalla et al. 2003)   
 Microdamage formation itself contributes to the toughness of bone through crack-
tip shielding.  (Vashishth et al. 2000; Vashishth et al. 2000)  Fatigue studies of 
microdamaged compact bone have demonstrated that very few in vivo cracks propagate 
during in vitro fatigue loading.  (O'Brien et al. 2003)  Cracks formed with in vitro 
mechanical testing often propagate to the same length as in vivo cracks.  Crack 
propagation models estimate the average microcrack length would be 91.2 µm due to 
microstructural barriers, and that remodeling most likely targets the longest cracks for 
removal. (Taylor 1998; Sobelman et al. 2004)   
 The role of microdamage in the toughness of trabecular bone is less studied, but it 
is probable that toughening mechanisms similar to cortical bone at the microstructural 
level are in play.  Bovine trabecular bone has been shown to have fatigue and creep 
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characteristics similar to cortical bone. (Zilch et al. 1980)  However, it is likely that 
fracture toughness of human trabecular bone is variable due to large variations in density 
and architecture.  Its organization as a cellular solid also distinguishes its toughness 
behavior from cortical bone: while crack propagation can easily turn unstable in cortical 
bone, crack propagation is quantum-controlled in trabecular bone as individual trabeculae 
fail.  (Cook et al. 2009)  In such a structure, it is advantageous for damage to localize 
within already damaged trabeculae, as the damage remains contained and the structure 
can be repaired or replaced.  Transverse struts may act as sacrificial elements, protecting 
the integrity of load-bearing longitudinal elements as they dissipate energy.  (Badiei et al. 
2007)  More data into crack growth mechanisms in trabecular bone is needed, as 
correlations with cortical bone mechanisms can only go so far. 
2.4 Bone Microdamage 
In a seminal study conducted by Harold Frost in 1960, in vivo microcracks in 
human ribs were differentiated from cracks formed during bone sample extraction by an 
en bloc basic fuchsin staining technique, demonstrating that microcracks form in the 
body due to physiological loading. (Frost 1960) It is now understood that microdamage 
formation and repair is an integral part of bone homeostasis in which both structural and 
material properties are modulated to maintain bone strength. (Seeman et al. 2006; Cheung 
et al. 2008)  When a microcrack occurs, signaling mechanisms are activated which target 
that area for repair.  Although the signaling process is not fully elucidated, evidence 
suggests that a disruption to the canalicular network connecting nearby osteocytes is 
responsible for osteocytic apoptosis, which may initiate the targeted remodeling process. 
(Verborgt et al. 2000; Verborgt et al. 2002; Noble 2005; Cardoso et al. 2009)  Damaged 
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areas are resorbed and replaced with new osteoid, which then mineralizes over time to 
restore matrix to its original state.  
The role of microdamage in skeletal fragility is fiercely debated:  while some 
studies have shown decreased strength and stiffness with microdamage accumulation, 
(Carter et al. 1977; Burr et al. 1997; Yeh et al. 2001) others view damage accumulation 
as a toughening mechanism which allows for the release of strain energy. (Vashishth et 
al. 1997)  Linear microdamage is associated with a quadratic loss of modulus which 
propagates more easily than diffuse damage, which can dissipate energy while limiting 
propagation. (Burr et al. 1998; Diab et al. 2006) In studies of fatigue life of bone with 
age, it was found that bone from younger individuals had a longer fatigue life due to the 
formation of diffuse damage, whereas bone from older donors formed fewer but longer 
linear microcracks. (Diab et al. 2006) Others have shown that the osteonal arrangement 
of cortical bone serves to arrest crack development and prevent damage propagation to 
overt fracture. (Hazenberg et al. 2006) A critical length of damage may be necessary to 
initiate targeted remodeling. (Sobelman et al. 2004)  Thus, while the initiation of damage 
in itself may not be instrumental in apparent fracture, it is clear that microdamage 
morphology is important in assessing fracture risk due to damage accumulation. 
2.4.1 Bone microdamage studies with bisphosphonates and fracture risk 
Since bisphosphonate therapy is commonly prescribed in osteoporosis, it is 
important to examine the consequences of long-term suppression of bone turnover.  
Bisphosphonates can reduce bone turnover by as much as 80-90%, which increases bone 
density. (Turner 2002)  However, they also suppress remodeling and cause increased 
bone mineralization, leading to an accumulation of microdamage that can degrade 
 25 
mechanical properties and increase the brittleness of bone.  It is important to understand 
the implications of microdamage accumulation in bisphosphonate-treated bone and 
determine if such accumulation leads to a weakening of bone matrix and subsequent 
increased fracture risk. 
Many studies have attempted to define the role microdamage accumulation plays 
in bisphosphonate treatment.  Suppression of bone resorption leads to damage 
accumulation in the elderly (Lee et al. 2003), and Flora demonstrated that dogs receiving 
0.5 mg/kg/day of etidronate or clodronate fractured ribs spontaneously within 12 months. 
(Flora et al. 1981)  Furthermore, rib, spinous process, or pelvic fractures were observed in 
dogs treated between 9 and 12 months with high doses of bisphosphonates.  However, it 
is unclear whether these fractures were caused by an accumulation of microdamage or 
other factors. (Burr et al. 1997)  In another study by Forwood, fracture incidence was 
evaluated in dogs treated for 2 years with risedronate.  Researchers found no 
microdamage accumulation or observed no spontaneous rib fractures, despite reduced 
bone turnover of 80-90%. (Forwood et al. 1995) Furthermore, another study found that a 
certain amount of pre-existing microdamage actually increases fatigue resistance in 
cortical bone. (Sobelman et al. 2004)  The same study also showed that damage induced 
during fatigue loading was greater in cortical bone samples from older individuals, 
indicating an age-related increase in susceptibility to microcracking.  Bouxsein has 
suggested that, while microdamage accumulation is clearly associated with reduced 
mechanical properties, the ability of bone to undergo microdamaging under load is in fact 
a toughening mechanism that dissipates energy and helps prevent propagation of large 
microcracks through the matrix. (Bouxsein 2003) The multitude of researchers in this 
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field has yet to come to a consensus on the role of microdamage in bisphosphonate-
treated bone and fracture risk. 
2.4.2 Fluorescent Labeling of Microdamage 
 In 2000, Lee et al published a microdamage detection technique which allowed 
for site-specific fluorescence of damage.  Microdamage forms cracks in the 
hydroxyapatite matrix which exposes unbound charged ions, 55% of which are calcium 
ions. (Lee et al. 2003)  Lee was able to use fluorescent agents to form a strong chelate 
with unbound calcium ions lining the crack walls, allowing for site-specific detection of 
microdamage.  In the study, Lee bulk stained human rib sections in 1% solutions of 
alizarin complexone, calcein, calcein blue, oxytetracycline, xylenol orange, and basic 
fuchsin.  Microcrack density and length were quantified, and no differences between the 
stains were noted.  Dyes were then applied sequentially to bovine trabecular bone 
samples undergoing compressive cyclic fatigue testing to enable labeling of crack 
growth.  However, the transition between dyes was imprecise, and there was evidence of 
stain substitution in some areas. (Lee et al. 2000) 
 O’Brien et al improved the sequential labeling technique by using ion 
chromatography to measure the affinity of each fluorochrome for free calcium.  Dye 
concentrations were optimized and applied to fatigue tested compact bone in orders of 
decreasing affinity.  Stain substitution was therefore minimized, and they were able to 
demonstrate microdamage accumulation at different intervals in the fatigue test. (O'Brien 
et al. 2002)  Since publication of this study, others have used the sequential staining 
technique to study propagating microcracks in ovarectomized sheep, (Kennedy et al. 
2008) the effect of loading mode on crack propagation, (Wang et al. 2006) the fracture 
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behavior of bone at high strain rates in equine femurs, (Kulin et al. 2008) and the three-
dimensional distribution of microdamage in trabecular bone. (Bigley et al. 2008) 
2.4.3 Alterations in Bone Composition in Age-related Fragility and Microdamage 
Many have speculated that compromising the bone matrix and mineral interaction 
leads to an age-related decrease in bone strength. (Boskey 2003; Paschalis et al. 2004; 
Wang et al. 2004)  Ager hypothesized that collagen cross-linking chemistry changes with 
age, which may contribute to deterioration in bone quality. (Ager et al. 2005)  Also, 
Boskey found that collagen crosslinking is predictive of future fracture risk. (Boskey 
2003)  Accumulation of advanced glycation end-products (AGEs) with age may 
contribute to increased fragility with aging, specifically through reduction in post-yield 
energy dissipation capacity. (Nyman et al. 2006) Therefore, many studies have linked 
increasing age to compromised bone matrix/mineral material, leading to a decrease in 
mechanical properties and toughness of bone (Wang et al. 2004).   
 A study examining the chemical composition of bone near areas of microdamage 
revealed a decreased carbonate/protein ratio and carbonate/phosphate ratio, and increased 
acid phosphate content. (Ruppel et al. 2006) It is speculated that increased tissue 
mineralization hastens the formation of microdamage, (Burr et al. 2003) but this study 
found no significant differences in phosphate/protein ratio or crystallinity between 
microdamaged and undamaged bone.  Collagen crosslinking structure was also different 
in microdamaged areas, suggesting ruptured crosslinks.  However, it is unclear whether 
these changes cause damage to form, or whether these changes are the result of damage 
formation since areas that were analyzed had already demonstrated cracking.  
2.5 Micro-CT and its Use in Studying Trabecular Bone 
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 Microcomputed tomography (micro-CT) is a powerful technology allowing three 
dimensional analyses of tissues at high resolution in a nondestructive manner.  In 
trabecular bone studies, automated calculation of properties such as mineral content; 
trabecular thickness, spacing, and number; degree of anisotropy; and relative geometry of 
trabeculae (rod-like versus plate-like) allow quick and easy descriptions of trabecular 
bone organization.   
 Micro-CT works by measuring the X-ray attenuation (absorption) of the tissue, 
which is dependent on its density.  Small variations in density can be resolved by micro-
CT depending on the resolution of the detector.  Images are taken slice by slice in three 
orthogonal directions, and a three-dimensional reconstruction array is directly created, 
rather than reconstructing a 3D image from series of two-dimensional slices. (Feldkamp 
et al. 1989; Tuan 2006)   
 Micro-CT systems have been used extensively to study alterations in trabecular 
bone structure due to age, gender, anatomical location, and pathology such as 
osteoporosis.  In one study, human bone biopsies taken at five different skeletal sites 
were analyzed using micro-CT and 3D analysis methods. (Hildebrand et al. 1999) 
Trabecular bone in the femoral head was defined by high bone volume fractions, thick 
trabeculae, and plate-like structure.  In the lumbar spine, analysis of the second and 
fourth vertebrae showed that bone volume fraction was lower than the femoral head, with 
thinner and more rod-like trabecular architecture.  Analysis of the calcaneus revealed a 
structure similar to the lumbar spine, but with increased bone volume fraction.  In the 
iliac crest, trabecular bone architecture was more varied, suggesting a mixed structure 
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type between the lumbar spine samples and the femoral head samples.  This study 
demonstrates that trabecular architecture is dependent on anatomical site.  
Recently, Mueller et al obtained morphometric indices from formalin-fixed radii 
of 50 men (mean age 79.7 ± 9.1 years) and 50 women (mean age 81.5 ± 8.9 years) at six 
different locations, beginning with the subchondral trabecular bone and ending near the 
middle of the diaphysis. (Mueller et al. 2009) In general, they found that most 
morphometric parameters differed significantly in gender and were independent of the 
analyzed region of interest.  Total bone volume, trabecular bone volume density, and 
trabecular number were greater in men compared with women.  The most significant 
differences in trabecular bone volume density were noted in the more distal regions, and 
gender differences evened out with sharp decreases in men as values were calculated 
along the radial shaft.  Women also demonstrated thinner trabeculae in the metaphyseal 
regions, but thicker trabeculae in the diaphyseal regions.  Another study compared 
trabecular bone architecture in the proximal femur between osteoporotic and non-
osteoporotic populations. (Borah et al. 2001) Dramatic decreases in bone volume, 
connectivity density, and trabecular thickness are seen in osteoporosis, with related 
increases in trabecular spacing and more rod-like architecture.  All of these studies 
demonstrate the power of micro-CT to characterize trabecular organization 
nondestructively, and suggest that architecture varies by age, gender, and anatomical 
location.  
2.6 Finite Element Modeling in Bone Mechanics Studies 
 Finite element modeling (FEM) is a numerical technique used to solve a series of 
differential equations describing the physical behavior of a sample under a set of input 
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conditions.  The advent of high resolution micro-CT scans has improved FEM studies of 
trabecular bone mechanics because the actual behavior under input conditions can be 
studied rather than behavior of an idealized trabeculated structure.  Individual voxels 
(three-dimensional pixels) generated in the CT images can be converted into equally 
sized hexahedral elements in the finite element model.  This sub-divides the sample into a 
series of smaller regions consisting of elements and nodes.  Mathematical equations 
describing the displacement of nodes under a fixed load, for example, can be used with 
constitutive equations to predict how the sample will behave.   
 FEM has been used in the field of bone mechanics to describe the behavior of 
bone under physiological loading conditions, failure, and in pathologic states like 
osteoporosis. (Lotz et al. 1991; Lotz et al. 1991; Borah et al. 2001; Bevill et al. 2009)  
Generally, bone behavior is modeled under conditions of linear elasticity, homogeneity, 
isotropy, and small strains due to computational time and space constraints.  Since bone 
behaves like a linear elastic material these assumptions are valid within certain limits. 
(Pugh et al. 1973; Pistoia et al. 2002) This concept has been shown in earlier studies, 
where using linear elastic FE analyses in combination with experimental data provided 
good results for the prediction of the bone failure load measured in experiments. (Lotz et 
al. 1991; Pistoia et al. 2002)  Nagaraja specifically addressed the question of whether 
using inhomogeneous FE analysis rather than homogenous assumptions would improve 
the correlation strength and provide more precise stress/strain estimations of damage 
events. (Nagaraja et al. 2007) A modest improvement (<8%) in correlation strength of 
stress/strains to damage sites was found using inhomogeneous analysis.  Stress/strain 
magnitude estimations were different by less than 9% between the two models.  Thus, an 
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improvement in model estimations is achieved using inhomogeneous material properties, 
but the differences are modest.  Furthermore, a study carried out in pelvic trabecular bone 
compared an idealized homogenous FE model to a more “realistic” model containing 
inhomogeneous material properties. (Dalstra et al. 1995) They also found that for 
comparative studies, homogenously distributed material properties can be assumed.   
Finally, trabecular bone within the femoral neck and intertrochanteric regions has 
demonstrated significant anisotropic behavior; however, Brown et al demonstrated that 
incorporating anisotropic properties in two-dimensional FE models results in no 
significant changes in stress distributions. (Brown et al. 1984; Lotz et al. 1991)  Based on 
these previous studies, use of FEM under conditions of homogeneity, isotropy, and linear 
elasticity to study the microstructural stresses/strains of trabecular bone at the onset of 
structural yielding is validated within the linear elastic region for comparative studies.   
 In conclusion, much progress has been made in the microdamage field in the past 
30 years.  With the improvements in micro-CT and finite element modeling, it has 
become possible to study trabecular bone mechanics to greater depths than ever before.  
This thesis uses these improvements in technology and builds upon the work of others to 












AGING AND GENDER EFFECTS ON MICROSTRUCTURAL STRESS AND 
STRAIN ASSOCIATED WITH DAMAGE INITIATION  
 
3.1 Introduction 
Peak bone mass is reached at approximately age 30, after which a slow decline in 
bone mass begins throughout the skeleton at rates that vary among individuals and 
anatomical sites.  For trabecular bone in particular, age-related changes include 
alterations in remodeling, extracellular matrix heterogeneity and composition (e.g. 
collagen and noncollagenous proteins, mineral, and water content), quantity (bone 
volume fraction), and microarchitecture (e.g. trabecular thickness, orientation, degree of 
anisotropy, and structure model index). (Hildebrand et al. 1999; Paschalis et al. 2004; 
Recker et al. 2004; Busse et al. 2009) Of these factors, reductions in bone quantity with 
corresponding alterations in microarchitecture have been the most extensively studied. 
Decreased bone volume fraction with age is typically associated with microstructural 
deterioration in the form of decreased trabecular thickness and connectivity with 
increased trabecular spacing and anisotropy. (Parfitt et al. 1983; Kimmel et al. 1990)   
While architectural changes with aging in the trabecular bone are well 
documented, sex differences are less concrete.  Histomorphometric studies have found 
few bone volume fraction or compressive strength differences attributable to sex in 
vertebral trabecular bone in age matched groups. (Bergot et al. 1988; Thomsen et al. 
2000; Keaveny et al. 2002)  One study reported an increased tendency for perforation of 
horizontal trabecular struts and increased trabecular spacing between horizontal 
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trabeculae in females compared with males, but found no other histomophometric sex 
differences. (Mosekilde 1989)  It seems clear that architectural differences in trabecular 
bone between sexes are subtle, but less clear are sex differences in the response to 
damaging loads at the microstructural level.  A recent study by Yeni et al reported a 
possible sex difference in the relationship between shear stress amplification and 
variability of stresses in the trabecular bone response to mechanical load.  (Yeni et al. 
2008)  However, more research in this area is warranted.  
Alterations in bone mass and microstructure are not the only phenomena that 
contribute to increased fragility. Decreased bone quality is also reflected in an 
accumulation of unrepaired microdamage, which may be the result of a breakdown in 
targeted remodeling of microdamage regions. (Burr et al. 1998; Burr et al. 2008)  The 
relationship of microdamage with skeletal fragility has been previously investigated, and 
non-linear increases in crack density with age have been reported. (Schaffler et al. 1995; 
Burr et al. 1997; Mori et al. 1997; Fazzalari et al. 1998; Fazzalari et al. 2002) Gender 
differences in damage accumulation are less clear.  One study found a similar prevalence 
of diffuse damage between males and females, but greater areas of diffuse damage in 
male bone, suggesting that while damage initiation factors may be similar between sexes, 
the mechanisms of damage progression and its removal may be gender-related. (Vashisth 
et al 2000)  However, studies are inconclusive at this time. 
In the present study, age and sex-related differences in micromechanical 
properties associated with microdamage initiation are investigated using a previously 
published technique which combines histology and 3D micro-CT reconstructions of 
trabecular bone with finite element modeling. (Nagaraja et al. 2007)   Microstructural 
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stresses and strains associated with microdamage initiation of severe, diffuse, and linear 
morphologies were quantified in trabecular bone from the distal femur of younger 
women, older women, and older men. Additionally, changes in microarchitecture and 
mineralization were evaluated in association with trabecular bone microdamage initiation 
of different morphologies.  We hypothesize that the stress threshold for microdamage 
initiation is lower in trabecular bone from older females but similar between genders, 
indicating a loss in bone quality with aging.  
3.2 Methods 
3.2.1 Specimen preparation  
Fresh-frozen (-80°C) trabecular bone cores (18 mm in length, 5 mm in diameter) 
were harvested from the distal femur of three younger females (32-37 years old, n=9), 
three older females (71-80 years old, n=9), and three older males (68-78 years old, n=9) 
such that the principal material direction was approximately aligned with the loading 
axis.  Based on available medical records, donors selected for this study did not have any 
prior history of metabolic bone diseases, osteoporotic fractures, or metastatic cancers. 
Stainless steel endcaps (5 mm depth) were glued to ends of each bone core specimen 
using cyanoacrylate glue (Prism 401, Loctite, Newington, CT, USA) to minimize the 
effects of end artifacts on mechanical testing data and prevent movement within the end-
caps. (Keaveny et al. 1994) The specimens were wrapped in saline soaked gauze and 
stored at -20° C for one week until mechanical testing. (Linde et al. 1993)  
3.2.2 Micro-CT imaging  
All specimens were micro-CT imaged (µCT 40, Scanco Medical, Basserdorf, 
Switzerland) at a voxel resolution of 21 µm. A threshold to distinguish trabecular bone 
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from background was chosen through histogram analysis of grayscale images and 
remained consistent throughout all evaluations. Automated distance transformation 
algorithms were used to calculate morphological parameters including bone volume 
fraction, trabecular thickness, spacing, number, structural model index (SMI), 
connectivity and trabecular orientation (Hildebrand et al. 1999). Trabecular orientation 
was measured as the angle from the principal axis of the trabecula to the loading axis. 
Trabecular bone mineralization (in mg/cc HA) was computed from attenuation values of 
grayscale micro-CT images based on hydroxyapatite (HA) calibration standards. 
Specifically, for calibration of the linear attenuation coefficient (1/cm) to hydroxyapatite 
(HA) mineral density (mgHA/cm3), a cylindrical HA phantom (ScanCo Medical, 
Basserdorf, Switzerland; 38mm diameter) was utilized. This phantom contained known 
density rods (0, 200, 400, and 800 mgHA/cm3) embedded in resin. Scans were performed 
at the X-ray source energy used in this study (45 kVp).  A 0.5mm Al filter was used for 
all scans. Reconstructions also incorporated a beam hardening correction curve. 
3.2.3 Mechanical testing 
Using a servo-hydraulic mechanical testing system (Mini Bionix 858, MTS 
Corp.), specimens were preconditioned for 3 cycles to 0.1% strain followed by a uniaxial 
compression ramp at a rate of 0.5% strain/s to 0.9% for female donors and 1.2% for male 
donors and held for 3 hours. (Figure 3.1) The yield strain endpoints were determined in 
preliminary testing, and it was decided that samples should be tested to a point consistent 
with the yield point on the stress-strain curve (using the 0.2% offset method) rather than 
the same yield strain which may not reflect the true yield point.  Apparent strain was 
calculated using an effective gage length, defined as the exposed length plus half the 
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length embedded in the endcaps (Keaveny et al. 1997). Specimens were immersed in 
0.9% physiologic saline plus protease inhibitors (Protease Inhibitor Cocktail Set V, 






















Figure 3.1 Strain yield differences between male and female donors.  Using the 0.2% 
offset method, different strain yields were found in preliminary testing of trabecular bone 
samples from male and female donors in the distal femur.  Sample sizes were small (n=3 
donors/group), and additional testing with more donors for gender differences in strain 
yield points did not replicate these results.   
 
3.2.4 Labeling, identifying, and classifying microdamage  
Microdamage was detected using a sequential fluorescent labeling technique 
(O'Brien et al. 2002; Lee et al. 2003). Prior to mechanical testing, specimens were stained 
with 0.02% alizarin complexone for 8 hours at 4º C and atmospheric pressure to label 
pre-existing microdamage. Pre-existing microdamage included damage created from 
specimen extraction, exposed calcium in resorption cavities created during bone 
remodeling, and microdamage sustained in vivo prior to death. To improve stain 




USA) and the top endcap was attached only after staining with alizarin complexone. 
After mechanical testing, the top endcap was carefully removed from samples using a 
diamond saw (Isomet 1000, Buehler Ltd., USA) to improve stain penetration. Specimens 
were then stained with 0.005% calcein for 8 hours at 4º C and atmospheric pressure to 
label microdamage incurred from mechanical testing.  
After staining, specimens were dehydrated in a series of graded alcohols and 
embedded in methyl methacrylate (MMA).  Prior to embedding, specimens were secured 
in custom alignment fixtures to facilitate registration of histological sections to 
corresponding micro-CT sections for the same specimen. MMA blocks were sectioned 
into 150-200 µm thick longitudinal slices on a diamond saw and mounted with Eukitt’s 
mounting medium (EM Sciences, USA) onto glass slides.  
Microdamage was assessed using 100X magnification (optical resolution: 1.11 
µm) in the central four histology sections from each sample. The microdamage analysis 
region omitted trabeculae immediately adjacent to specimen edges to exclude trabeculae 
damaged by the coring process or end-cap removal.  Pre-existing microdamage area was 
quantified with grayscale images taken under red epifluorescence. Test-induced 
microdamage area was quantified with grayscale images taken under green 
epifluorescence (Image-Pro Plus, Media Cybernetics, USA).  
Microdamage was identified based on the criteria that cracks are intermediate in 
size (larger than canaliculi but smaller than vascular channels), have sharp borders, and a 
focus plane demonstrating depth of field (Burr et al. 1990; Huja et al. 1999). A 
classification system published by Moore and Gibson was modified to group test-induced 
damage into three morphological categories: severe, linear, and diffuse damage (Arthur 
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Moore et al. 2002; O'Neal et al. 2010). Severe damage was classified as either 
microdamage consisting of one primary crack with minor secondary cracks or through-
thickness cracks, linear damage included both single and parallel cracks, and diffuse 
damage consisted of cross-hatch damage that was either equal in length and intensity (to 
distinguish it from severe damage) or damage with a large area of distribution (Figure 
3.2).   
 
 
Figure 3.2. Description of Microdamage Morphological Categories. Damage was 
separated into three categories based on morphology.  Bullet points indicate metrics used 
to categorize individual trabeculae.  
 
 
Trabeculae exhibiting calcein-stained damage only were selected for finite 
element analysis (n=100 total trabeculae per age group).  In the young female group, 44 
severe, 20 linear, 17 diffuse, and 19 undamaged trabeculae were analyzed.  In the old 
female group, 39 severe, 13 diffuse, 22 linear, and 26 undamaged trabeculae were 
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analyzed.  In the old male group, 72 severe, 71 diffuse, 104 linear, and 26 undamaged 
trabeculae were analyzed.    
3.2.5 Finite element analysis  
Micro-CT images were used to create 3-D high-resolution finite element (FE) 
models for estimating the local stress and strain distributions (FEA software, Scanco 
Medical, Basserdorf, Switzerland). After thresholding the micro-CT images, individual 
voxels within the images were directly converted into 4-6 million hexahedral finite 
elements by assigning nodal connectivity and bone tissue properties. Approximately six 
voxels (21 µm/voxel) spanned the mean trabecular thickness, which provided accurate 
solution convergence (Guldberg et al. 1998). A conjugate gradient solver with an 
element-by-element matrix vector multiplication scheme allowed for the estimation of 
tissue-level stresses and strains (Van Rietbergen et al. 1996). A homogeneous linear 
isotropic analysis was utilized, and a Poisson’s ratio of 0.3 was assumed.   
The tissue modulus was back-calculated to match the apparent modulus obtained 
during testing of the specimens (Van Rietbergen et al. 1995). The back-calculated tissue 
moduli for the pre-menopausal group were 9.6 GPa (32 year old), 9.2 GPa (37 year old) 
and 10.7 GPa (37 year old). The back-calculated tissue moduli for the post-menopausal 
group were 10.5 GPa (71 year old), 10.3 GPa (76 year old) and 9.5 GPa (80 year old).  
The back-calculated tissue moduli in the older male group were 10.4 GPa (78 year old), 
13.2 GPa (77 year old), and 11.5 GPa (68 year old).  Boundary conditions simulating a 
0.9% uniaxial compressive strain in female bone samples and 1.2% strain in male bone 
samples were applied to models to match the loading conditions in mechanical testing. 
Von Mises equivalent stresses/strains and maximum compressive principal 
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stresses/strains were extracted from the FE analysis. Microdamaged and undamaged 
trabeculae identified under green epifluorescence were then visually registered to the 
same trabeculae within the finite element models (demonstrated for the female group in 
Figure 3.3 for damaged and Figure 3.4 for undamaged), and average stress within each 
extracted trabecula was calculated. 
 
 
Figure 3.3. Representative microdamaged trabeculae extracted from histology sections 
and homogeneous finite element models (von Mises effective stress shown) for young 
and old donors.  
 
 
Figure 3.4. Representative undamaged trabeculae extracted from histology sections and 





One-way ANOVA was used to determine interdonor global architectural 
differences in each group.  Interdonor differences were not significant for most 
architectural parameters (BV/TV, degree of anisotropy, SMI, trabecular number, and 
mineralization).  Among older female donors, trabecular spacing was significantly 
different (p=0.04).  Among younger female donors, trabecular thickness (p=0.04) and 
connectivity (p=0.05) were significantly different.  Among older male donors, BV/TV 
(p=0.03), trabecular thickness (p=0.002), and trabecular spacing (p=0.02) were 
significantly different.  Trabecular number, degree of anisotropy, SMI, mineralization, 
and connectivity were similar.  
  T tests were performed to determine statistically significant differences between 
age groups for the global architectural parameters reported in Table 3.1 after verifying 
normality.  For comparisons of microstructural mechanical and architectural factors by 
damage category and age or sex, Kruskal-Wallis nonparametric tests with Mann-Whitney 
post-hoc pairwise comparisons were run for each combination of damage category and 
age or sex group to determine significant differences in the interaction.  Since this 
approach may increase the probability of committing a Type I error, a Bonferroni 
correction was applied to the alpha level for pairwise comparisons within mechanical 
factors (VM and principal stress and strain) and architectural factors (mineralization, 
SMI, thickness, and orientation).  This reduces the significance level of the tests to 
0.0125.  All values are reported as mean ± standard error.  
3.3 Results 
3.3.1 Global Architectural Comparisons by Age and Sex 
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 Analysis of the global architectural characteristics of the trabecular specimens by 
micro-CT evaluation showed that older men and women were similar in their bone 
volume fraction, trabecular thickness, degree of anisotropy, SMI value, trabecular 
number, trabecular spacing, and connectivity density.  Mineralization was higher in men 
compared with women (Table 3.1, p<0.001).   
Global trabecular microarchitecture between younger and older women was 
similar for most architectural parameters (Table 3.1). There was a trend for increased 
trabecular number (p=0.07) and decreased trabecular spacing (p=0.10) in younger 
women.  Trabecular bone from younger women contained more redundant struts 
compared to bone from older women (p=0.01), and average mineralization for the 
younger specimens was significantly lower (p<0.001) compared to older specimens.  
 
Table 3.1. Global Architecture and Mineralization Comparisons by Age and Sex 
1144.4 (6.0)+1062.8 (6.7)*+1022.0 (7.5)*Mineralization (mg HA/cc)
5.57 (1.06)5.17 (0.62)$7.21 (0.54)$Connectivity Density (mm-3)
0.69 (0.05)0.64 (0.03)0.58 (0.02)Trabecular Spacing (mm)
1.40 (0.10)1.45 (0.07)1.57 (0.04)Trabecular Number (mm-1)
1.03 (0.11)0.93 (0.14)1.03 (0.11)Structural Model Index
1.79 (0.14)2.00 (0.13)1.87 (0.14)Degree of Anisotropy
161.5 (9.9)153.3 (9.0)153.9 (12.0)Trabecular Thickness (µm)
0.180 (0.017)0.198 (0.021)0.212 (0.012)Bone Volume Fraction
Old MaleOld FemaleYoung FemaleParameter
*,+,$ indicates where pairwise comparisons between groups achieved significance (p<0.01)  
 
3.3.2 Microstructural Stress/Strain Differences by Sex 
 In preliminary testing, the strain yield for women was determined to be 0.9% and 
1.2% for men.  In order to directly compare microstructural stresses/strain values 
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obtained from finite element modeling between the groups subjected to different strain 
endpoints, results were normalized to the maximum apparent stress/strain applied during 
the mechanical test resulting in a stress/strain amplification value.  In other words, the 
resulting normalized stress/strain values reflect the degree of amplification of the 
trabecular mechanical value relative to the applied stress or strain.   
 Microstructural von Mises and principal stresses showed similar results (Figure 
3.5 a and b).  A significant difference in the stress amplification between severe and 
undamaged trabeculae was found in the female group (p<0.01).  When microstructural 
von Mises and principal strain amplification was analyzed, a gender-related difference 
was observed for severely damaged trabeculae.  Severely damaged trabeculae from men 
were associated with a decreased microstructural strain/apparent strain ratio than women 
(p<0.01).  Differences within each gender group demonstrated significantly greater 












































































Severe Diffuse Linear Undamaged
 
Figure 3.5. The 95% CI for normalized damage initiation stress levels by gender.  A 
significant difference in the 3.5a. von Mises and 3.5b. principal stress amplification level 
of severely damaged trabeculae relative to undamaged in older females is observed. Bars 













































































Figure 3.6.  The 95% CI for normalized damage initiation strain levels by gender.  
For both 3.6a. von Mises and 3.6b. principal strain, severely damaged trabeculae in older 
males was significantly decreased compared with older females.  Severely damaged 
trabeculae were also more strained than undamaged in both sexes.  Bars indicate 












3.3.3 Microstructural Stress/Stain Differences by Age 
 Differences in microstructural stresses and strains were found among damaged 
trabeculae between younger and older women. Severely damaged trabeculae possessed 
significantly higher von Mises and principal stresses than linear and undamaged 
trabeculae (Figure 3.7 a and b, p<0.001) in both the young and old age groups.  In older 
subjects, undamaged trabeculae were under significantly lower von Mises and principal 
stress than all other damage types (p<0.001).  A significant decrease in the von Mises 
stress of undamaged trabeculae in older donors compared to undamaged younger donors 
was observed. (p<0.01) and approached significance in the principal stress data 
(p=0.014). 
 Analysis of von Mises and principal strains revealed similar relationships to the 
stress results.   In both the young and old age groups, severely damaged trabeculae 
possessed von Mises and principal strains that were significantly greater than linear and 
undamaged trabeculae (Figure 3.8 a and b, p<0.003).  Diffusely damaged trabeculae in 
younger women had greater von Mises and principal strains than linearly damaged and 
undamaged trabeculae (p<0.01).  In the older female age group, undamaged trabeculae 
were under less strain (von Mises or principal) compared with all other damage types 
(p<0.003).  Among undamaged trabeculae, the older female group was under less strain 
than the younger female group for both strain measures (p=0.014 for principal strain, 







































































S e v e re D iffu se L in e a r U n d a m a g ed  
Figure 3.7.  The 95% confidence intervals for 3.6a. von Mises and 3.7b. principal 
compressive stress initiation ranges calculated by damage category. A significantly 
greater stress range is demonstrated in young, undamaged trabeculae compared with old, 
undamaged trabeculae.  Significant increases are also seen in the stress state of severely 
damaged trabeculae compared to linear and undamaged trabeculae in both age groups.  
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S e v e r e                      D if fu s e                       L in e a r   U n d a m a g e d
 
Figure 3.8.  The 95% confidence intervals for 3.8a. von Mises and 3.8b. principal 
compressive strain initiation ranges calculated by damage category. Significant 
increases were seen in the strain state of severely damaged trabeculae compared to linear 











3.3.4 Microarchitectural Differences by Sex 
 Architectural characteristics of damaged and undamaged trabeculae were 
analyzed and compared between the two gender groups.  Mineralization values were 
increased for all damage categories in the male group compared with females (p<0.01), 
but no differences were found between damage categories (Figure 3.9a).  Diffusely 
damaged trabeculae were significantly thicker than linearly damaged and undamaged 
trabeculae in the male group (Figure 3.9b, p<0.01).  In the female group, severely 
damaged trabeculae were oriented closer to the loading axis compared with undamaged 
trabeculae (Figure 3.9c, p<0.01), but no such relationship was observed for male bone 
samples.  No relationship between damage type and structural model index was found 













































































































































Figure 3.9. Trabecular bone microarchitecture and mineralization by gender.  3.9a. 
Diffusely damaged trabeculae in males were significantly thicker than linear and 
undamaged trabeculae.  3.9b. Severely damaged trabeculae in the female group were 
oriented closer to the loading axis than undamaged trabeculae. 3.9c. No significant 
differences in SMI were found. 3.9d. Male trabeculae were significantly more 
mineralized in all damage categories compare with female trabeculae. Bars indicate 













3.3.5 Microarchitectural Differences by Age 
Individual trabeculae which underwent micromechanical analysis were also 
characterized by their structural model index (SMI), trabecular orientation, trabecular 
thickness, and mineralization to determine whether damaged trabeculae possessed 
different microarchitecture than undamaged trabeculae (Figure 3.10). Analysis of the 
SMI showed that severely damaged trabeculae are more rod-like than undamaged 
trabeculae in both pre- and post-menopausal groups (p<0.003, Figure 3.10a). Trabecular 
orientation was assessed to determine whether damage preferentially occurred in 
trabeculae oriented at particular angles from the loading axis (Figure 3.10b).  In older 
samples severely damaged trabeculae were more commonly oriented along the 
longitudinal axis of the specimen in line with the loading axis (p<0.01). In younger 
samples linearly damaged trabeculae were at a significantly greater angle compared to the 
loading axis than both severe (p<0.001) and diffusely damaged (p=0.001) samples.   
When trabecular thickness was examined, severely damaged trabeculae in the older age 
group were significantly thinner than undamaged trabeculae (p<0.01).  In the pre-
menopausal group, severely damaged trabeculae were thinner than linearly damaged 
trabeculae (p<0.01, Figure 3.10c). Local mineral density was evaluated (Figure 3.10d), 
and severe, diffuse, and undamaged trabeculae were significantly more mineralized in the 
older age group compared to the younger age group (p<0.001).  
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Figure 3.10. Trabecular bone microarchitecture and mineralization for young (32-
37 year old) and old (71-80 year old) age groups. 3.10a. Trabecular thickness is 
plotted, indicating that severely damaged trabeculae are thinner than undamaged in the 
older age group, and thinner than linearly damaged trabeculae in the younger age group 
(p<0.01). 3.10b. Trabecular orientation relative to the loading axis is plotted, indicating 
that in the older age group, trabeculae aligned more acutely with the loading axis are 
more likely to sustain severe damaged compared to undamaged trabeculae.  3.10c. SMI is 
plotted, showing more rod-like trabecular architecture in severely damaged trabeculae 
compared to undamaged trabeculae in both groups (p<0.01). 3.10d. In severely damaged, 
diffusely damaged, and undamaged trabeculae, the trabecular mineralization was 










3.3.6 Microdamage Quantification Differences by Sex 
 Pre-existing damage incidents were counted from male and female donors.  
Levels of pre-existing damage were not different between the sexes (females: 1.5 ± 0.1 
incidents/mm2, males: 1.1 ± 0.1 incidents/mm2).  Among pre-existing damage types, 
linear microdamage was most prevalent (0.63 ± 0.05 incidents/mm2 in males, 0.71 ± 0.08 
incidents/mm2 in females), significantly greater than the severe morphology in both 
males (0.19 ± 0.03 incidents/mm2, p<0.001) and females (0.14 ± 0.03 incidents/mm2, 
p<0.001) and greater than diffuse damage levels in males as well (0.33 ± 0.04 
incidents/mm2, p<0.002).  Levels of test-induced damage (0.80 ± 0.1 incidents/mm2 in 
males vs 1.52 ± 0.1 incidents/mm2 in females, p<0.001) and damage demonstrating both 
fluorophores (0.72 ± 0.1 incidents/mm2 in males vs 1.50 ± 0.2 incidents/mm2 in females, 
p<0.001) were significantly greater in females compared with males.   
3.3.7 Microdamage Quantification Differences by Age 
The number of pre-existing severe and diffuse damage incidents was significantly 
greater in the older group (0.14 ± 0.03 and 0.64 ± 0.09 incidents/mm2, respectively) than 
the younger group (0.03 ± 0.01 and 0.23 ± 0.04 incidents/mm2, respectively; p<0.003).  
The number of pre-existing linear damage incidents was not different (0.71 ± 0.09 
incidents/mm2 in the older group vs. 0.64 ± 0.05 incidents/mm2 in the younger group). 
Levels of severe, linear, and diffuse test-induced damage in the older group (0.48 ± 0.08, 
1.67 ± 0.1, 0.82 ± 0.09 incidents/mm2, respectively) was not significantly different from 
the younger group (0.59 ± 0.09, 2.03 ± 0.17, 1.03 ± 0.1 incidents/mm2, respectively).  
Levels of damage demonstrating both fluorophores were very similar between age groups 
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(1.4 ± 0.16 incidents/mm2 in the younger group vs 1.5 ± 0.23 incidents/mm2 in the older 
age group).  
3.4 Discussion 
In this study, the stress and strain state of damaged and undamaged trabeculae 
from three groups, younger females, older females, and older males were compared to 
investigate whether age or gender-related differences existed in the micromechanical 
loading environment associated with microdamage initiation.  Trabecular bone cores 
were stained with two calcium-chelating fluorescent dyes to separate in vivo damage 
from damage incurred from uniaxial compression loading to the yield strain (0.9% for 
women, 1.2% for men).  Trabeculae exhibiting test-induced damage only were registered 
to solutions of principal and von Mises stresses and strains obtained from linear image-
based finite element analysis.  Results suggest that microdamage morphology is highly 
dependent on both the stress and strain magnitude, and that trabecular bone from younger 
women may be able to sustain higher stresses/strains without damaging compared with 
trabecular bone from older women.  Furthermore, trabeculae developing severe damage 
may undergo significantly less relative deformation in older men compared with older 
women.   
It is unclear whether a stress or strain-based criterion for damage initiation is most 
appropriate, and whether shear forces are important. In our study of aging effects on 
damage initiation, stress values were scaled using a back-calculated tissue modulus 
unique to each trabecular bone sample.  We obtained a similar average tissue modulus 
between age groups (9.8 GPa for the older female group vs 10.2 GPa for the younger 
female group), so our corrections had a small impact on the age-related stress differences.  
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However, in the only age-related difference found among undamaged trabeculae, we 
observed the greatest differences using von Mises stress to characterize the 
micromechanical environment.  Others have used von Mises stress to define 
microdamage formation and character, and the association between shear forces and 
cross-hatched damage morphology has been documented. (Fyhrie et al. 2000; Yeni et al. 
2003; Yeni et al. 2008)  Thus stress-based criteria with shear factors may be more 
sensitive to differences between groups than strain-based criteria, depending on the 
magnitude of the difference between tissue-level stiffness.    
In our investigation of gender effects on microdamage initiation, differences in 
yield strains between males and females required microstructural stress and strain 
estimations to be normalized by the maximum strain and stress applied in order to 
compare between groups.  In the stress data, no differences between genders were noted 
after accounting for differences in tissue-level stiffness (male: 11.5 GPa MPa vs female: 
9.8 GPa).  A statistically significant decrease in the strain amplification value for severely 
damaged trabeculae was found in male bone compared to female bone.  This would 
suggest that trabecular struts in men underwent less deformation relative to the total 
structural deformation prior to fracture than female bone, and is supported by trabecular 
mineralization data which showed greater mineralization in all damage types in male 
donors.  However, this difference may also be a result of the normalization by strain 
yield; since strains in female donors were normalized by a value less than 1, and strains 
in male donors were normalized by a value greater than 1, small strain differences were 
accentuated.  To confirm these results, additional testing at the same strain yield in bone 
from donors with similar mechanical properties should be done.   
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 We found that the older group had significantly increased levels of pre-existing 
damage compared with the younger group, but incidents of test-induced damage were 
actually higher in the younger group compared to the older group.  These results indicate 
that pre-existing damage has an effect on subsequent damage formation, and has 
implications for our conclusions.  Although the stress and strain values reported were 
obtained only for de novo damage, stress values were scaled according to the back-
calculated tissue modulus.  The fact that older bone had more pre-existing damage than 
younger bone results in an unequal deviation from the undamaged stiffness values 
between the age groups, meaning that the mechanical properties of our undamaged 
trabeculae in the old group may be underestimated, while the mechanical properties of 
the damaged trabeculae may be overestimated.  Applying a correction would shift 
undamaged stress values upwards, and decrease damaged stress values, lessening the 
differences between the groups.  Since the levels of pre-existing damage were similar 
between the older male and female groups, however, there would be no such effect on the 
stress values reported between older males and females.  Additionally, strain values 
would also be unaffected as they are not dependent on the back-calculated tissue 
modulus. 
 Analyses into local trabecular architecture of older females revealed that damage 
severity correlated with trabeculae that were thinner, more rod-like, and oriented closer to 
the loading axis than their undamaged counterparts. Incorporating these results with local 
stress/strain data, we observed that damaged trabeculae have higher stresses in part 
because they are thinner, more slender, and oriented closer to the loading axis. 
Architectural differences appeared to have less an effect on damage formation in younger 
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females and older males.  In addition, consistent with previous studies, we demonstrated 
that mineralization increases with age. (Paschalis et al. 1997; Boskey et al. 2005; 
McNamara et al. 2005)   
 Several important limitations must be considered when interpreting our data.  We 
analyzed replicates from each donor due to the dependence of mechanical parameters on 
location within the distal femur.  In order to obtain averages of tissue level behavior, we 
created a balanced design in which equal numbers of cores near the cortex and medullary 
cavity were analyzed.  In statistical analyses, damage incidents were considered 
independent events because all models were linear and did not consider effects of 
evolving stresses of neighboring trabeculae on the loading environment.  The donor 
effect is therefore random, and accounting for random factors associated with donors in 
ANOVA analysis did not affect outcomes.  While this strategy allowed us to 
simultaneously examine trabeculae possessing a wide range of architectural 
characteristics, more samples from different donors should be analyzed in order to make 
stronger conclusions about the general population.  Another limitation of our study is the 
use of a linear FE model, which may impact the magnitude of stresses and strains 
reported.  Non-linear trabecular yielding at the microstructural level would be expected to 
affect severely damaged trabecular behavior and stress distribution.  As this population 
represented a small percentage of total trabeculae (less than 1%), errors due to linear 
assumptions are not great enough to alter conclusions of the study.   A further limitation 
is the use of different strain yields in gender groups.  Additional testing with more donors 
did not replicate the strain yield differences in this study; therefore, results are not 
applicable to gender population differences.  
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 In conclusion, this study has demonstrated that microstructural stress and strain 
magnitude is highly associated with the formation of microdamage of different 
morphologies in three different groups: young females, old females, and old males. 
Trabecular stresses in undamaged trabeculae of older women were lower compared to 
younger women, suggesting that the threshold for damage initiation may be reduced in 
this group.  Also, strains associated with severely damaged trabeculae in men were 
significantly reduced compared to age-matched women.  Studies in bone from a larger 

































INCREASED NUMBERS OF PROPAGATING SEVERE DAMAGE INCIDENTS 
CONTRIBUTES TO DECREASED FATIGUE LIFE IN OLDER WOMEN 
 
4.1 Introduction 
 Fatigue microdamage of trabecular bone is formed after repeated loading in daily 
activities. (Burr et al. 1985)  Damage formation is not necessarily pathologic; 
microdamage effectively dissipates strain energy within normal loading ranges and limits 
the development of more serious fractures at sites of high stress. (Vashishth et al. 1997)  
Due to remodeling mechanisms, microdamaged regions of trabeculae are targeted for 
repair, thus preserving the structural integrity of the trabecular lattice. (Burr et al. 1985)  
With aging, however, targeted remodeling processes diminish, allowing fatigue 
microdamage to accumulate. (Schaffler et al. 1995; Allen 2008)  While isolated areas of 
linear crack accumulation have been shown to increase fatigue life, significant damage 
accumulation lowers stiffness and increases the probability of fracture. (Burr et al. 1998; 
Sobelman et al. 2004) 
   Morphological changes to trabeculae, including decreased thickness, increased 
spacing, loss of connectivity, increased anisotropy, and increased bone age and 
mineralization contribute to the deterioration of bone strength and stiffness and can 
promote microdamage formation and propagation. (Burr et al. 1997)  Extensively 
damaged trabeculae are resorbed by targeted remodeling mechanisms, which increase the 
probability of failure – loss of a few trabeculae has a large impact on strength and 
stiffness. (Guo et al. 1994; Burr 2002)  The effect of microdamage progression on 
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toughness changes with age has been studied extensively in cortical bone, (Schaffler et al. 
1995; Vashishth et al. 1997; Norman et al. 1998; Vashishth et al. 2000; Zioupos 2001; 
Zioupos 2001) but less so in trabecular bone.  (Seeman 2003; Cook et al. 2009) 
 In this study, trabecular bone cores from the femoral head of men and women 
aged 55-81 years were tested in a novel two step mechanical testing protocol in order to 
investigate the evolution of cracks of different morphologies under cyclic loads.  We 
hypothesize that bone from older individuals will demonstrate decreased resistance to 
crack propagation, though we do not expect to see differences due to gender. 
4.2 Methods 
 Femoral heads from 10 males and 10 females aged 55-81 years were obtained 
from the National Disease Research Interchange (NDRI).  Donors had no history of bone 
disease, cancer, or use of medication altering bone morphology.  Tissue was removed at 
autopsy within 12 hours of death and fresh frozen at -80°C.  Donors were initially 
divided into four groups based on gender and age: young males (60.2 ± 3.7 years; mean ± 
s.d.), old males (77.2 ± 1.5 years), young females (63.0 ± 2.8 years), and old females 
(72.8 ± 4.8 years).  After determining no gender-related differences in any measure, 
groups were combined to form two groups based on age (younger: 61.3 ± 3.1 years; 
older: 75.0 ± 3.9 years).    
 Two trabecular bone cores from each sample (5 mm diameter) were removed 
from the central portion of the femoral head using a trephine under constant irrigation 
with physiological saline such that the longitudinal axis was oriented approximately 
parallel with the material axis.  Cores were sized to a final length of 18 mm with a 
diamond saw.  Bone marrow was removed using a water pik (WP-72W, WaterPik, USA) 
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to improve stain penetration, and the ends of each core were glued with cyanoacrylate 
(Prism 401, Loctite, Newington, CT, USA) into stainless steel endcaps of 5 mm depth to 
minimize the effect of end-artifacts on mechanical testing.  (Keaveny et al. 1994)  Bone 
specimens were scanned with micro-CT at a voxel resolution of 16 um. (µCT 40, Scanco 
Medical, Basserdorf, Switzerland)  A threshold was chosen to distinguish bone from 
background for 3D reconstructions and evaluations, and the same threshold was used for 
all samples.  Evaluation of 3D reconstructed images yielded morphological descriptors 
(bone volume fraction, connectivity density, structural model index, trabecular number, 
trabecular thickness, trabecular spacing, and degree of anisotropy).  Bone mineralization 
(in mg/cc HA) was computed from attenuation values of grayscale micro-CT images 
based on hydroxyapatite (HA) calibration standards. 
4.2.1 Mechanical Testing 
 Each trabecular bone core (2 per donor, n=40) was mechanically tested using a 
two-step process (Figure 4.1). (Mini Bionix 858, MTS Corp.)  Throughout the 
mechanical testing process, specimens were immersed in 0.9% physiological saline and 
10 µmol/L protease inhibitor (E-64, Sigma Chemical) to prevent tissue degradation.  In 
the first portion of mechanical testing (Figure 4.1a), cores were preconditioned for 3 
cycles to 0.1% strain then loaded in static uniaxial compression at a strain rate 0.5% 
strain/second to a strain endpoint of 0.8% and held for three hours to create microdamage 
throughout the specimen.   
In the fatigue portion of mechanical testing (Figure 4.1b), samples were first 
preconditioned for 10 compression cycles under strain control from 0.05% to 0.45% 
using a sinusoidal waveform at a frequency of 2 Hz.  The initial modulus, E0, was 
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calculated from the linear best-fit of the 10th loading cycle.  Samples were then preloaded 
to 10 N and underwent compressive fatigue testing to a strain endpoint of 0.8% using a 
sinusoidal waveform at a normalized stress range (∆σ/E0) of 0.005 and frequency of 2 
Hz.  Previous studies have shown that using a normalized stress is advantageous in 
comparing samples with wide variations in elastic modulus associated with bone volume 
differences.  (Caler et al. 1989; Pattin et al. 1996; Moore et al. 2003)  Tests were stopped 
after reaching a strain level of 0.8%, a point within the linear region of apparent 
mechanical behavior and below the yield point of 0.9% used in previous studies. (O'Neal 
2010)  Preliminary testing showed that stopping the test at this level of strain rather than 
at failure limits the number of severe damage incidents observed, allowing for the study 
of microdamage progression of linear and diffuse damage morphologies as well as severe 
morphologies.  Also, previous studies have shown that stopping the tests at a 
predetermined maximum strain rather than at a set number of cycles correlated better 
with modulus reduction (an indication of damage accumulation), allowing for 
comparisons of fatigue mechanisms among samples with large strength and stiffness 
variations. (Moore et al. 2003)  A ceiling was placed on the maximum number of cycles 
(150,000 cycles) after strain ratcheting was no longer observed.  The number of cycles; 
plastic (1st cycle) and residual strain (last cycle); max strain at various time points; and 
the initial, preload, and final secant moduli were calculated for each specimen.  Plastic 
strain accumulation was measured at the first fatigue loading cycle (after 
preconditioning).   
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 4.1a. Step 1:  Static Uniaxial Compressive Loading under Displacement Control 
 
Figure 4.1 Stylized figure demonstrating two-step mechanical testing protocol.  4.1a. 
Part one of the mechanical testing protocol induced damage formation by compressing 
samples uniaxially to a strain end-point of 0.8%.  4.1b. Part two of the mechanical testing 
protocol allowed for microdamage progression by cyclically compressing samples 
uniaxially between -10 N and a maximum force calculated at a normalized stress level 
(∆σ/E0) of 0.005.  The test ended when a strain of 0.8% was reached.  
 
 
A two-step staining protocol with chelating fluorophores allowed for the study of 
changes in microdamage size and morphology between each portion of the mechanical 
test. (O'Brien et al. 2003) One core from each donor (n=20) was stained with 0.02% 
alizarin plus 10 µmol/L protease inhibitor at atmospheric pressure and 4°C for 8 hours 
after completion of the static loading portion of the mechanical test. Samples were 
stained again with 0.01% calcein after the cyclic loading portion of the mechanical test 
which labeled damage progression or de novo damage created in the fatigue portion of 































4.1b. Step 2:  Cyclic Uniaxial Compressive Loading under Load 
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cores most similar in gross morphological parameters (Table 4.1).  At the completion of 
mechanical testing and staining, cores were fixed in 70% ethanol for 24 hours then 
dehydrated using a graded alcohol infiltration procedure.  Cores were embedded in 
methyl methacrylate and 6 slides of 100-150 µm thickness were cut along the 
longitudinal axis with a diamond saw. 
4.2.2 Microdamage Analysis 
 Investigators were blinded to the demographic group of each sample for the 
microdamage analysis.  Three slides from each core corresponding with the middle 
section of the cylindrical sample were evaluated, and the microdamage analysis region 
omitted trabeculae immediately adjacent to specimen edges to exclude trabeculae 
damaged by the coring process or end-cap removal.  Microdamage was assessed at 100x 
and identified based on criteria that cracks are intermediate in size (larger than canaliculi 
but smaller than vascular channels), have sharp borders, and have a focus plane 
demonstrating depth of field. (Burr et al. 1990; Huja et al. 1999)  Alizarin-labeled 
damage, encompassing damage formed during the static-loading portion of the 
mechanical test as well as in vivo damage and incidental damage from the core 
extraction, was counted under red epifluorescence.  Calcein-labeled damage, including 
damage created de novo in the fatigue portion of the mechanical test as well as crack 
growth from initial alizarin-labeled damage, was counted under green epifluorescence. 
(O'Brien et al. 2002)  Cracks exhibiting both alizarin and calcein fluorescence were 
evaluated from a composite image generated from two images of the damage incident 
under each filter.  In all, over 1300 damage incidents were counted.  Damage counts were 
normalized by bone slide surface area obtained with image analysis software. 
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(Axiovision, Zeiss Corportation, USA)  Microdamage was classified into severe, diffuse, 
or linear morphological categories based on previously published criteria (Figure 4.6a, 
4.7a, and 4.8a). (O'Neal et al. 2010)  Propagated damage was classified based on whether 
alizarin and calcein-labeled damage areas were completely overlapping (contained), or 
whether the calcein-labeled areas extended beyond the initial alizarin-labeled damage 
area.  Linear damage length and diffuse and severe damage area were measured using 
image analysis software. (Axiovision, Zeiss Corporation, USA)   
4.2.3 Statistics 
 All statistical tests were conducted using Minitab statistical software.  Global 
architectural differences, number of cycles, differences in modulus, and plastic and 
residual strain were evaluated for age group differences with two way ANOVA using age 
group as a fixed factor and specimen donor as a random factor.  Differences in modulus 
within each age group at different points in mechanical testing were obtained with two-
way ANOVA using the modulus as a fixed factor and specimen donor as a random factor.  
Tukey post-hoc pairwise comparisons were made between the three modulus time points.   
 Three-way ANOVA and Tukey post-hoc comparisons were used for evaluating 
differences in crack density, crack propagation density, and length/area changes using 
age group and damage type as fixed factors and specimen donor as a random factor.  For 
all tests, p<0.05 was considered statistically significant.  
4.3 Results 
 No differences due to gender were noted for any comparisons, so gender groups 
were combined and comparisons were made between younger and older groups (younger: 
61.3 ± 3.1 years; older: 75.0 ± 3.9 years).  Gross morphological properties are reported 
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for all mechanically tested samples (two cores/donor, n=40) and microdamage-assessed 
samples (one core/donor, n=20).  An assessment of the global architectural properties of 
the trabecular bone samples revealed no significant differences between groups (Table 
4.1).   
 
Table 4.1 Architectural Characteristics of Trabecular Bone Samples by Age Group 
All Samples Microdamage-Assessed Samples  
Parameter Younger Older Younger Older 
Bone Volume Fraction 0.27 ± 0.02 0.23 ± 0.01 0.25 ± 0.02 0.23 ± 0.02 
Connectivity Density 8.26 ± 0.64 7.09 ± 0.56 7.71 ± 0.63 6.85 ± 0.68 
Structural Model Index 0.29 ± 0.20 0.63 ± 0.11 0.52 ± 0.17 0.63 ± 0.16 
Trabecular Number 1.60 ± 0.07 1.46 ± 0.05 1.56 ± 0.07 1.43 ± 0.06 
Trabecular Thickness 0.18 ± 0.01 0.18 ± 0.01 0.17 ± 0.01 0.18 ± 0.01 
Trabecular Spacing 0.61 ± 0.03 0.67 ±0.03 0.62 ±0.03 0.68 ±0.03 
Degree of Anisotropy 1.58 ± 0.05 1.62 ± 0.04 1.61 ± 0.08 1.65 ± 0.07 




 The number of cycles to the fatigue test endpoint approached significance 
between age groups (younger: 77372 ± 15984 cycles; older: 34944 ± 11964 cycles, 
p=0.06).  A number of samples reached 150,000 cycles, which was the ceiling placed on 
all tests due to the observation that the modulus had stopped declining and max strain had 
stopped progressing by this point.  In the younger group, 9 of 20 samples reached the 
limit, while only 3 of 20 samples reached the limit in the older group.  An average value 
for the maximum strain per cycle was plotted as a function of number of cycles to 
illustrate how strains progressed during fatigue testing (Figure 4.2).  Samples that went to 
150,000 cycles are plotted separately from younger and older samples because their 
maximum strain/cycle changed very little throughout the test.  
The elastic modulus of each sample was calculated at three intervals: at the initial 
static load to 0.8% strain, at the end of the 10th pre-conditioning cycle before fatigue 
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testing, and at the final cycle of the fatigue loading protocol.  The initial modulus was 
significantly greater than the pre-cyclic modulus and the final modulus in both the 























Figure 4.2.  Changes in maximum strain per cycle in younger samples, older 
samples, and samples that went to 150,000 cycles.  The greatest rate of change in 
maximum strain occurred within the first 100 cycles.  Samples in the older group tracked 
at higher strain rates/cycle than samples in the younger group.  Samples that went to 
































Figure 4.3. Elastic modulus changes during mechanical test by age group.  
Significant decreases in the elastic modulus after the initial static loading protocol were 
noted in both age groups.  No differences in modulus due to the fatigue test were found.  
Bars represent significant differences, p<0.05 considered statistically significant.  
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Plastic strain was calculated in the first cycle as the difference between the initial 
and final strain and did not vary between the age groups (εp = 0.0004 for both younger 
and older groups).  The residual strain upon unloading was obtained at the final cycle and 
did not differ between the age groups (εres = 0.03 for both younger and older groups).     
 Alizarin-labeled microdamage incidents (encompassing damage created in vivo, 
incidental damage created during core extraction, and damage created after the static 
load) were quantified and compared between younger and older age groups.  
Significantly increased incidents of linear damage relative to diffuse and severe damage 
were seen in both age groups (Figure 4.4, p<0.005). Also, significantly increased diffuse 
damage incidents compared to severe damage incidents were found in both age groups 
(p<0.005).  There was significantly more linear damage in the older age group after the 

































Figure 4.4. Microdamage density after initial static loading by age group.  Linear 
damage incidents were most common in both age groups, significantly increased over 
diffuse and severe damage incidents. (*)  Diffuse damage incidents were more common 
than severe damage incidents in both age groups.  Finally, linear damage incidents were 
increased in the older group compared to the younger group. Bars represent significant 
differences, p<0.05 considered statistically significant. 
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 Cyclic de novo damage was more rare, representing 6.7% of total calcein-labeled 
damage in the younger group and 7.1% in the older group.  Of de novo damage incidents, 
significantly more linear damage than severe damage was observed in both age groups 
(Figure 4.5, younger: p<0.04; older: p<0.001), and in the older age group, linear damage 































Figure 4.5 Microdamage density of de novo damage created with fatigue loading by 
microdamage morphology.  More linear damage than severe damage was found in both 
age groups, and linear damage density was greater than diffuse damage density in the 
older group as well. p<0.01; bars indicate significant differences.  
 
The percentage of damage propagating from static load-induced damage was not 
different between the age groups: 46% of the younger group and 43% of the older 
group’s static load-induced damage (alizarin-labeled) was classified as propagated 
(exhibiting dual-fluorescence).  Overwhelmingly, propagated damage adhered to the 
morphology it assumed at initial formation; less than 5% of total propagated damage 
changed morphological categories.   
Propagated damage was classified according to its fluorescence pattern.  Damage 
incidents demonstrating completely overlapping fluorescence of alizarin and calcein 
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labels were classified as contained damage, while calcein-labeled regions which 
increased the damage area or length of an initial alizarin-labeled damage incident were 
classified as extended damage (Figures 4.6a, 4.7a, and 4.8a).  It was found that more 
linear propagated damage was of the contained than extended type in both age groups 
(Figure 4.6b, p<0.001).  Linear damage which propagated had a smaller initial length 
than the contained damage, and increased to a final length similar to the contained 
damage length (Figure 4.6c).   
No age-related differences in the propagation character (extended vs. contained) 
were found among diffuse, propagated damage incidents, although the damage area for 
the younger group was significantly greater than the older group in the initial and final 
extended damage area (Figure 4.7b and c, p<0.05).  The percent of area expansion 
between the initial and final propagated area was greater in the younger group (34%) 
compared to the older group (23%) as well.  In damage of a severe morphology, damage 
incidents in the older group were significantly more extended than contained (Figure 
4.8b, p<0.02), while no differences were seen in the younger age group.  When the severe 
damage areas were compared, the younger group had a significantly larger damage area 
in the initial and final extended damage group compared with the older group. (Figure 
4.8c, p<0.02) The final extended damage area was also significantly greater than the 
damage area of contained propagation. (p<0.03)  However, the percent of area expansion 
between the initial and final propagated area were similar between the groups (13% 
increase in younger vs 12% increase in older).  Finally, evaluation of total propagated 
damage revealed no preferences in terms of contained or extended character in either age 

































































Figure 4.6. Linear propagated damage images, character, and length by age group. 
4.6a. Examples of the two groups of propagated linear damage, contained and extended, 
are shown under filters for each fluorescent stain as well as the composite image 
(alizarin=red, calcein=green). 4.6b. Comparisons of the number of contained versus 
extended damage incidents demonstrated that damage of a linear morphology was more 
likely to remain confined to its initial damage length in both age groups.  4.6c. Length 
measurements of linear damage incidents showed that the initial length of damage (initial 
extended) which extended during the fatigue test (final extended) did not exceed the 
length of contained linear damage incidents for both age groups. Bars represent 
significant differences, p<0.05 considered statistically significant. 










































































Figure 4.7. Diffuse propagated damage images, character, and length by age group.  
4.7a. Examples of the two groups of propagated diffuse damage, contained and extended, 
are shown under filters for each fluorescent stain as well as the composite image 
(alizarin=red, calcein=green). 4.7b. No significant differences by propagation type or age 
group were seen in diffuse damage incidents.  4.7c. Measurements of the initial extended 
diffuse damage area after static loading and final extended damage area after cyclic 
loading showed significant increases in the younger group compared to the older group.  
The final extended damage area did not exceed the damage area for contained damage in 
either age group. Bars represent significant differences; p<0.05 considered statistically 
significant.  











































































Figure 4.8. Severe propagated damage images, character, and length by age group.  
4.8a. Examples of the two groups of propagated severe damage, contained and extended, 
are shown under filters for each fluorescent stain as well as the composite image 
(alizarin=red, calcein=green). 4.8b. In the older age group, propagated severe damage 
was more likely to be extended than contained.  4.8c. Damage areas in the initial 
extended group after static loading and final extended group after cyclic loading were 
greater in younger compared to older groups. In the younger group, the final extended 
damage area was significantly greater than the contained damage area. Bars represent 
significant differences; p<0.05 considered statistically significant.  







 In this study, trabecular bone cores from the femoral head of 10 younger and 10 
older individuals were subjected to a two-step mechanical testing protocol.  Microdamage 
was first induced with static uniaxial compressive loading to 0.8% then propagated with 
cyclic uniaxial compressive loading under a modest normalized stress range.  Testing was 
confined within the region of linear elastic apparent behavior and stopped at a below-
yield strain of 0.8%.  It was found that samples from older donors reached the fatigue test 
endpoint with a significantly fewer number of cycles than younger individuals.  This is 
associated with greater numbers of extending severe damage incidents in the older group 
compared to the younger group.  
 In the fatigue portion of the mechanical test, we observed translation of the stress-
strain loop along the strain axis.  While some have suggested this translation is due to 
creep (Carter et al. 1983), further investigation has shown that it is due to microdamage 
accumulation and propagation. (Moore et al. 2003; Moore et al. 2003; Moore et al. 2004)  
In this study, examination of the changes in maximum strain with cycle showed sharp 
increases in the first 100 cycles of the fatigue test, then slower increasing strain until the 
test endpoint.  Furthermore, the strain tracked highest in samples from older donors, and 
lowest in samples that went to 150,000 cycles.  The greater change in strain from cycle 2 
to cycle 100 found in samples from older donors (0.0008) compared with samples from 
younger donors (0.0006) and samples that went to 150,000 cycles (0.0004) demonstrates 
the differences in the initial rate of microdamage propagation between these groups and 
may be an important indicator of crack resistance. 
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At the normalized stress level used in this study, we did not observe significant 
differences in the linear crack density or crack length in either age group due to cyclic 
loading.  Others have also reported that crack length remains fairly stable in in vitro 
loading protocols due to microstructural barriers that arrest crack propagation.  (Wang et 
al. 2006)  Since there are few differences in the linear damage data between the static and 
cyclic loading protocol as well as between the age groups, it is unlikely that these damage 
incidents have a large impact on trabecular bone’s progression towards failure. 
 In diffusely damaged trabeculae, a larger damage area was found in younger 
individuals compared with older individuals.  Furthermore, the percent area expansion 
was also greater in younger compared with older trabecular bone.  This result is at odds 
with the observation that the strain endpoint was reached more quickly in samples from 
older donors than younger donors. Rather, it illustrates an efficient energy dissipation 
strategy which protects the overall structural integrity of the trabecular bone lattice by 
localizing damage expansion with a morphology that is less likely to propagate. (Diab et 
al. 2005; Badiei et al. 2007; Cook et al. 2009)  Thus, it does not appear that this 
mechanism is the driving force behind the age-related differences in the number of cycles 
between the younger and older donors. 
Examination of severe damage density showed that, while the number of severe 
damage incidents was similar between the two age groups, cracks in samples from older 
donors were more likely to be expanding in area with fatigue. Despite the large 
differences in severe damage area between the age groups, the percent of damage 
expansion was very similar between the groups.  This suggests that the age-related 
differences in the time to the fatigue strain endpoint were driven by the number of severe 
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damage incidents that were expanding, rather than the damage area of severely damaged 
trabeculae.  It is advantageous to concentrate damage progression in trabeculae which are 
already compromised because finite element modeling studies have demonstrated that the 
probability of overt fracture increases as the number of failed trabeculae increases. (Guo 
et al. 1994; Cook et al. 2009)  Differences in bone mineral age and density, alterations in 
collagen quality, and other changes in the composition of the bone matrix may play a role 
in severe damage expansion. (Currey et al. 1996; Zioupos 2001; Wang et al. 2002; 
Seeman 2003) 
It was surprising to see that the initial severe damage area of younger individuals 
was so much greater than older individuals.  This observation is likely to be an artifact of 
the mechanical testing protocol.  It is probable that the older bone was initially more 
damaged, and that sites vulnerable to damage initiation due to a concentration of 
strains/stresses already exhibited microcracks. (Schaffler et al. 1995; Vashishth et al. 
1997)  In the less damaged core from younger donors, vulnerable sites would be more 
likely to experience higher stresses/strains at damage initiation than in vivo, resulting in 
more extensive initial damage.  This phenomenon has been noted before in the 
investigation of damage initiation stresses/strains in alendronate-treated bone, where 
decreased amounts of severe damage were formed in alendronate-treated bone which had 
increased levels of in vivo damage compared to controls. (O'Neal et al. 2010)  In this 
study, damage formed in vivo was not explicitly labeled separately from mechanical test 
induced damage due to the inability to differentiate between three stains, although others 
have shown that this is possible.  (O'Brien et al. 2003)    
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We did not note a change in the elastic modulus between the beginning and end of 
the cyclic loading protocol in any of the groups.  Further investigation revealed that the 
samples that reached 150,000 cycles experienced an average increase in the elastic 
modulus of 11%, while all other samples experienced an average decrease in modulus of 
2% (p<0.02).  This phenomenon has been observed in many previously published studies 
of fatigue loading in trabecular bone.  (Linde et al. 1987; Michel et al. 1993; Moore et al. 
2003)  It is possible that a viscoelastic steady state had not been reached in the first 10 
preconditioning cycles of the fatigue test, leading to an underestimation of stiffness. 
(Linde 1994)  The effect would be particularly pronounced in samples that went to 
150,000 cycles due to their greater initial stiffness (419.9 ± 34.7 MPa in 150,000 cycle 
samples vs. 317.1 ± 99.5 MPa in all others) relative to other samples.  (Linde 1994; 
Sobelman et al. 2004) 
There are a number of limitations to consider in interpreting these results.  All 
mechanical tests were carried out at room temperature rather than body temperature.  
This could have the effect of prolonging fatigue life, and has been shown to increase 
fatigue life by a factor of three in bovine cortical bone. (Carter et al. 1976)  Also, strain 
levels used in this study, while remaining at levels below the uniaxial yield strain, are still 
higher than would be expected due to physiological loading. (Yang et al. 2011)  For 
gender comparisons, no differences in number of cycles or the amount of microdamage 
were found, though achieved power (1-β=0.2 for both parameters) was too low to detect 
subtle differences.  Although consistent with other studies failing to show gender 
differences in fatigue life, the study should be expanded to explore gender differences 
further. (Sobelman et al. 2004)  Finally, damage morphology and stain location were 
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evaluated from thin slides, which may result in some erroneous classifications if 
additional cracks or evidence of damage propagation extended into the plane 
perpendicular to the evaluated planes.  The large number of damage incidents evaluated 
in this study should limit the influence of such errors if they occurred.   
In conclusion, a novel mechanical testing protocol was used to characterize the 
propagation of microdamage in trabecular bone of the proximal femur in younger and 
older individuals.   A decreased number of cycles to the test endpoint in older individuals 
were attributed to the damage area expansion of a greater number of trabeculae exhibiting 
severe damage morphology.  These results add to the growing body of work exploring 
fatigue damage mechanisms in trabecular bone and particularly those mechanisms which 



























ONE YEAR OF ALENDRONATE TREATMENT LOWERS 




 Alendronate, a bisphosphonate used to treat low bone density associated with 
osteoporosis, has been shown to decrease fracture risk at both vertebral and non-vertebral 
sites. (Liberman et al. 1995; Seeman 1999; Iwamoto et al. 2008)  It achieves this risk 
reduction principally by increasing bone mineral density at the structural level.  Positive 
effects at the tissue level may also improve fracture risk early in treatment by improving 
trabecular microarchitecture and reducing the number of trabecular stress risers (unfilled 
resorption pits) at sites of remodeling. (Seeman 2007)  Studies conducted in canine 
models have shown, however, that one year of alendronate treatment is associated with 
decreased toughness and increased microcrack density, though these two findings may be 
the result of different mechanisms since further investigation found them to be unrelated. 
(Allen et al. 2006)  Furthermore, studies by Stepan et. al. found increased crack density 
in osteoporotic women using alendronate compared to treatment-naïve osteoporotic 
controls, whereas another study of osteoporotic women did not find significantly 
increased microdamage frequency compared to cadaver controls. (Stepan et al. 2007)  A 
better understanding of the mechanistic basis of damage formation with alendronate 
treatment can provide new insight into the underlying mechanisms of bone fragility.  
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Bone derives its ability to resist fracture by forming microdamage when subjected 
to loading.  Traditionally, microdamage in trabecular bone has been grouped into two 
different morphological categories: linear microcracks and diffuse damage. 
Histologically, linear microcracks are identified as individual, sharply defined cracks, 
while diffuse damage referst to a cluster of cracks. (Wenzel et al. 1996; Reilly et al. 
2000)  It has been shown that different damage morphologies affect the biomechanical 
properties of bone differently (Burr et al. 1998; Diab et al. 2005; Diab et al. 2006). 
Diffuse damage formation plays a significant role in prolonging the fatigue life of bone 
and resisting a catastrophic fracture. (Burr et al. 1998; Diab et al. 2005)  In contrast, 
linear microcracks can reduce bone strength and stiffness and are traditionally associated 
with the terminal phase of fatigue fracture characterized by rapid crack propagation and 
catastrophic failure. (Burr et al. 1998; Diab et al. 2005)  Severe damage (defined by 
Moore and Gibson as a primary crack with secondary cracks, or through-trabecular 
thickness cracks) also occurs at a later stage in the fracture process (Arthur Moore et al. 
2002; Wang et al. 2006)  Although microdamage accumulation has been documented 
with alendronate use, its significance to bone fragility is still unknown. (Stepan et al. 
2007) 
 We have previously reported a specimen-specific finite element technique to 
assess trabecular level stresses associated with microdamage initiation in bovine 
trabecular bone. (Nagaraja et al. 2005; Nagaraja et al. 2007) With this technique, the 
relationship between local damage events and trabecular stress magnitude can be directly 
assessed and associated with trabecular architectural characteristics.  The overall goal of 
the study was to investigate whether changes in bone quality occurring after one year of 
 81 
alendronate treatment will result in an increased propensity to form microdamage.  The 
specific objectives were to (a) quantify the von Mises stress state of trabeculae 
demonstrating different morphologies of damage and compare between alendronate-
treated and control groups, and (b) to determine if changes in microarchitectural 
characteristics due to alendronate treatment are associated with damage morphology.   
5.2 Materials and Methods 
5.2.1 Animals 
Detailed methods regarding alendronate administration for this study have been 
previously reported. (Allen et al. 2006)  Briefly, one-year-old female beagle dogs were 
randomized into three groups and treated with oral doses of saline (1.0 mL/kg/day) or 
alendronate (ALN, 0.2 mg/kg/day or 1.0 mg/kg/day) for one year. The ALN 0.2 and ALN 
1.0 doses approximate the clinical doses used for the treatment of postmenopausal 
osteoporosis and Paget’s disease, respectively.  The group treated with saline served as 
the control group. All procedures were approved by the Indiana University School of 
Medicine Animal Care and Use Committee.  
5.2.2 Sample Extraction 
Twelve right distal femurs from beagle dogs (n=4 in each treatment group) were 
obtained for analysis.  One trabecular core from each specimen (diameter = 5 mm; length 
= 18 mm) was extracted by coring through the condyle of the distal femur in the 
approximate principal material direction using a trephine under constant irrigation with 
0.9% physiological saline + 10 µmol/L protease inhibitor (E-64, Sigma Chemical) 
followed by sizing with a diamond saw.  The protease inhibitor (PI) was used throughout 
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the experiment to minimize tissue degradation. The specimens were wrapped in saline-
soaked gauze and stored at -20°C until testing.  
5.2.3 Microdamage labeling, Micro-CT imaging, and Mechanical Testing 
Bone marrow was removed from trabecular cores using a water pik (WP-72W, 
WaterPik, USA) to improve stain penetration, and one endcap was placed on the end of 
each sample.  Trabecular cores were stained for 8 hours in 0.02% Alizarin ComplexOne 
+ 10 µmol/L PI at 4°C then washed with distilled water for 1 hour to label pre-existing 
damage, encompassing either in vivo damage or damage occurring from the core 
extraction.  The ends of the trabecular cores were glued into 5 mm deep stainless-steel 
endcaps to minimize end artifact effects in the mechanical test. (Keaveny et al. 1994)  
Samples were imaged with micro-computed tomography (µ-CT; µCT 40, Scanco 
Medical, Basserdorf, Switzerland) at a voxel resolution of 20 µm prior to mechanical 
testing.  Trabecular cores were then mechanically tested, in which they were first 
preconditioned for 3 cycles to 0.1% strain then loaded in displacement-controlled 
uniaxial compression (Mini Bionix 858, MTS Corp.) at a rate of 0.5% strain/second to 
the yield strain (determined to be 1.2% in preliminary testing) and held for 3 hours.  The 
apparent strain was calculated using a gauge length of the exposed length of the bone 
measured with digital calipers plus half the length of each bone end embedded in 
endcaps. (Keaveny et al. 1997)  Throughout testing, bone cores were immersed in 0.9% 
physiological saline + 10 µmol/L PI.   
After testing, one endcap was removed with the diamond saw to improve stain 
penetration, and cores were stained with 0.01% calcein to label test-induced 
microdamage for 8 hours at 4°C then washed with distilled water for 1 hour. (Vashishth 
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D 1994; O'Brien et al. 2002)  After staining, cores were fixed in 70% ethanol for 24 hours 
then dehydrated using a graded alcohol infiltration procedure.  Cores were embedded in 
methyl methacrylate in a prescribed orientation which allowed visual registration with the 
3D reconstructed µ-CT image, and 6 slides of thickness 150 µm were obtained along the 
longitudinal axis with the diamond saw from each sample.     
5.2.4 Microdamage Identification and Classification 
Test-induced microdamage was identified based on the criteria that cracks are 
intermediate in size (20 – 150 µm; larger than canaliculi but smaller than vascular 
channels), have sharp borders, and a focus plane demonstrating depth of field. (Allen et 
al. 2006; Stepan et al. 2007)  Areas of diffuse staining with no clearly defined cracks 
were not counted as microdamage.  A classification system published by Moore and 
Gibson was modified to group damage into three broad morphological categories: severe, 
linear, and diffuse damage (Figure 5.1). (Arthur Moore et al. 2002)  Severe damage was 
classified as either microdamage consisting of one primary crack with minor secondary 
cracks or cracks propagating through the thickness of the trabecula.  Linear damage 
included both single and parallel cracks, and diffuse damage consisted of cross-hatch 
damage that was either equal in length and intensity (to distinguish it from severe 
damage) or damage with a large area of distribution.   
Damage was observed at 100x magnification using fluorescence microscopy and 
quantified by an investigator blinded to the treatment group, then re-evaluated by a 
second investigator also blinded to the treatment group.  A 70% concordance rate in the 
number of damage events identified between each investigator was obtained, with the 
highest concordance rate being in the severe group (88%), and the lowest concordance 
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rate being in the linear damage group (60%).  Any differences in the count were 
reconciled between the two investigators, so that the total damage count is confirmed by 
both investigators.  An area of interest for damage analysis was generated on each slide 
by excluding tissue less than 500 µm from each sample edge.  Damage incidents 
demonstrating three staining patterns were counted and normalized by surface area (crack 
density, #/mm2).  A damage incident is defined as a discrete damage event, so that both 
linear and diffuse damage occurrences as classified by Figure 5.1 would each count as 
one damage event.  The three patterns of staining were 1) those which fluoresced 
predominantly under red epifluorescence corresponding to the emission wavelength of 
alizarin, 2) those which fluoresced predominantly under green epifluorescence 
corresponding to the emission wavelength of calcein, and 3) those which fluoresced 
under both red and green epifluorescence equally in intensity and location. 
5.2.5 Micro-CT Image Processing and Finite Element Analysis  
 3D micro-CT reconstructions of trabecular bone cores were thresholded to 
distinguish bone from background, and automated distance transformation algorithms 
were used to compute morphological parameters such as bone volume fraction, trabecular 
thickness and connectivity, structural model index (SMI), and degree of anisotropy (DA).  
Mineralization values were computed from attenuation values of grayscale µ-CT images 
based on hydroxyapatite (HA) calibration standards.   
Micro-CT images were used to create 3-D high-resolution finite element (FE) 
models for estimating local stress distributions (FEA software, Scanco Medical, 
Basserdorf, Switzerland).  A homogeneous, linear elastic, isotropic model was used, and 
an initial tissue modulus of 10 GPa and a Poisson ratio of 0.3 were assumed.  Using 
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Scanco software, individual damaged and undamaged trabeculae identified first during 
histological microdamage categorization were extracted from the 3-D reconstructed µ-CT 
image manually (Table 5.1).  By manually delineating trabeculae from the reconstructed 
µ-CT image rather than the FEM estimation of stress distribution, the investigators were 
not influenced by the stress predictions when determining cut-off points.  Values for von 
Mises stress along the extracted trabeculae were obtained by averaging the values of all 
elements from the FEM solution corresponding to the voxels of the extracted trabeculae. 
(Figure 5.1)  Stress results were scaled to the back-calculated tissue modulus using a 
previously published procedure. (van Rietbergen B 1995)  Briefly, the apparent modulus 
obtained from mechanical testing within the elastic region is compared to the predicted 
apparent modulus computed from finite element models which used an initial estimate of 
the trabecular tissue modulus (10 GPa).  The ratio of the apparent modulus obtained from 
mechanical testing and predicted by finite element is multiplied by the initial estimate of 
the tissue modulus to obtain the effective tissue modulus based on mechanical testing 
results.    
 





























Percentages indicate the proportion of each damage type counted relative to total 




Figure 5.1. Microdamage description and classification, with FEA von Mises stress 
predictions. Linear damage includes a) single cracks and b) parallel cracks. Diffuse 
(crosshatch) damage includes c) cracks with equal crosshatching and d) cracks over a 
large area distribution.  Severe damage includes e) one primary crack with minor 
secondary cracks and f) cracks through the trabecular thickness.  
 
5.2.6 Statistics  
 All statistical tests were performed using MINITAB software (Minitab, Minitab 
Inc., USA).  Differences in global architectural parameters between the two treatment 
groups and the control group were deduced using Kruskal-Wallis nonparametric tests.  
Differences in crack density were determined with ANOVA analysis followed by Tukey 
pairwise comparisons.  p<0.05 was considered significant.  
To determine differences in mechanical and architectural parameters of damaged 
and undamaged trabeculae by treatment group and microdamage category, Friedman’s 
statistical test was conducted for the treatment groups and the four damage categories.  
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Kruskal-Wallis nonparametric tests were used to determine differences between damage 
categories within each treatment group, followed by post-hoc nonparametric pairwise 
comparisons.  A Bonferroni correction was used, as five measures (von Mises stress, 
mineralization, trabecular thickness, SMI, and trabecular orientation) were made on each 
analyzed trabeculae. This reduced the p value for a significant difference to p≤0.01. All 
data are presented as mean ± standard error. 
5.3 Results 
Comparisons of alendronate’s effect on the global properties of trabecular bone 
are shown in Table 4.1.  Alendronate-treated trabecular bone exhibited trends towards 
increased bone volume fraction, mineralization, trabecular thickness, trabecular number, 
and connectivity density, though none of these differences were significantly different 
than controls. There were no significant differences between the apparent moduli 
obtained during mechanical testing of alendronate samples compared to controls, nor 
were there differences in the back-calculated tissue moduli of alendronate-treated 
samples compared to controls.  No dose-dependent differences in apparent properties 
were noted. 
Figure 5.2 shows the crack density separated out as those cracks that were either 
alizarin or calcein stained only, cracks exhibiting overlapping fluorescence, and total 
damage (all cracks independent of color).  There was a significantly greater density of 
alizarin-labeled cracks in the treated groups compared with cracks exhibiting overlapping 
fluorescence (p<0.05).  No significant differences in crack density were seen across 
groups for calcein-labeled cracks or in total damage.   
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Figure 5.2 Total damage quantified based on fluorescence and plotted by treatment 
group.  The total damage columns are created by totaling damage counted in the three 
previous columns for each treatment group, and no significant differences were found.  
Bars represent significant differences.  p<0.05, mean ± SE. is plotted 
 
 
 In order to determine the effects of alendronate treatment on tissue level 
biomechanical properties, trabecular level von Mises stresses were compared to controls 
at microdamaged sites.  As shown in Figure 5.3, severely damaged trabeculae in the 
control group were under the greatest von Mises stress, significantly greater than severely 
damaged trabeculae in both of the alendronate treatment groups (p<0.001).  A treatment 
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effect was also discerned in the linearly damaged group, where the von Mises stress state 
of the linearly damaged control group was significantly greater than both alendronate 
treatment groups (p<0.01).   
 
 
Figure 5.3 Von Mises stress plotted by treatment group and damage morphology.  
The stress state of trabeculae exhibiting severe and linear damage was decreased in both 
treatment groups compared with controls.  In the control group, severe damage was 
associated with the greatest stress compared with all other damage groups.  In both 
treatment groups, the stress state of severely damaged trabeculae was significantly 
increased compared with linear and undamaged trabeculae.  Bars between damage 
morphologies within the same treatment group indicate significant differences. p<0.01 
indicates significance, mean + SE is plotted.   
 
 
The stress state of trabeculae exhibiting different damage morphologies were also 
compared within each treatment group.  Severely damaged trabeculae in the control 
group were under significantly greater stress than all other damage morphologies in the 
same group (p<0.01).  In both alendronate treatment groups, severely damage trabeculae 
were under greater stress than linear and undamaged trabeculae in the same group 
(p<0.01).  Finally, diffusely damaged trabeculae in the ALN1.0 treatment group were 
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under significantly greater stress than linear and undamaged trabeculae in that group 
(p<0.01).   
 Alterations in local mineral density were analyzed by treatment group and 
damage morphology. No differences due to dosage were observed, so the two treatment 
groups were combined.  Diffusely damaged trabeculae were significantly more 
mineralized in bone treated with alendronate compared to controls (p<0.01).  Similarly, 
undamaged trabeculae were significantly more mineralized in treated compared with 
untreated controls (p<0.001).  Within the treated group, severely damaged trabeculae 
were less mineralized than undamaged trabeculae (p<0.01, Figure 5.4a).   
To determine whether trabecular architectural characteristics were associated with 
damage morphology, trabecular thickness, structural model index, and trabecular 
alignment were computed for each extracted trabecula undergoing stress analysis.  No 
differences in any of these architectural parameters were found between the two 
alendronate treatment doses; thus, the data were pooled and compared to controls.  
Severely damaged trabeculae were thinner than trabeculae sustaining other damage types 
in alendronate-treated samples (p<0.01, Figure 5.4b); this was not true for the control 
group. Analysis of the SMI values for damaged trabeculae revealed that severely 
damaged trabeculae subjected to alendronate treatment were more rod-like than their 
diffusely damaged counterparts (p<0.01, Figure 5.4c).  Finally, the trabecular orientation, 
computed as the angle between the material axis and the loading axis, was significantly 
more acute in severely damaged trabeculae compared to undamaged trabeculae of the 
treated group (p<0.01).  Severely, linearly, and diffusely damaged trabeculae were also 
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more aligned with the loading axis compared with undamaged trabeculae from the 
control group (p<0.01, Figure 5.4d).   
 
 
Figure 5.4 Trabecular mineralization and architectural characteristics plotted by 
treatment group and damage morphology.  There were no differences due to treatment 
dose, so the two samples were combined. 5.4a. Trabecular mineralization is plotted with 
respect to damage morphology and treatment; severely damaged trabeculae were less 
mineralized than undamaged trabeculae in the treated group. Within diffuse and 
undamaged trabeculae, treatment was associated with increased mineralization relative to 
control.(*) 5.4b. Trabecular thickness is plotted with respect to treatment and damage 
morphology; severely damaged trabeculae were significantly thinner than other 
trabeculae in the treated group.  5.4c. Structural model index is plotted with respect to 
damage morphology and treatment; severely damaged trabeculae are more rod-like than 
diffusely damaged trabeculae. 5.4d. The angle between the principal material axis and the 
loading axis is plotted; undamaged trabeculae were generally aligned perpendicular to the 
loading axis in both treatment and control groups.  Bars indicate significant differences 
between damage morphologies within the same group.  p<0.01 indicates significance, 
mean + SE plotted 





































































































































 In this study, a novel method of determining tissue-level mechanical and 
architectural parameters associated with microdamage morphology was used to assess the 
effect of alendronate on trabecular bone microstructure.  Others have inferred that 
trabecular von Mises stresses increase with damage severity, but this is the first study that 
quantifies microstructural stresses by damage morphology. (Arthur Moore et al. 2002; 
Yeni et al. 2003)  This study concludes that alendronate administration alters the tissue 
level biomechanical properties of trabecular bone, resulting in a decreased von Mises 
stress necessary for initiation of severe and linear microdamage. 
 Many previously published studies have utilized the fluorescent staining protocol 
developed by O’Brien et al. to separate in vivo damage from test-induced damage. 
(O'Brien et al. 2002; Wang et al. 2005; Zarrinkalam et al. 2005)  In our execution of this 
protocol, we were able to separate cracks formed in vivo from those induced during 
uniaxial compression loading by examining their fluorescence under green and red 
epifluorescence.  Though total in vivo damage was not significantly greater in 
alendronate treated bone, linear crack density was increased in this population, which is 
in agreement with previously published work. (Allen et al. 2006)  However, it was 
difficult to determine whether cracks which fluoresced under both red and green 
epifluorescence equally are the product of crack propagation, double staining due to the 
sharing of calcium binding sites between the two fluorophores, or filter interference.  Due 
to these difficulties, we chose to exclude cracks which exhibited this overlapping 
fluorescence from the stress analysis due to the uncertainty of their origins.  
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 Previous studies have correlated microdamage formation to trabecular shear 
stress, suggesting that shear forces play a significant role in trabecular bone failure. 
(Fyhrie et al. 2000; Yeni et al. 2003; Yeni et al. 2008)  The contribution of shear forces to 
failure can be evaluated with the von Mises stress parameter, which is commonly used to 
predict yielding in complex loading conditions when the shear stress reaches a critical 
value on the octahedral plane.  Fyhrie et al demonstrated that von Mises stress 
concentrations correlated with sites of cracking in mechanically tested and in vivo 
damaged trabecular bone. (Fyhrie et al. 2000)  Our findings suggest that trabecular bone 
treated with alendronate may be more susceptible to severe and linear microdamage 
formation because of a decreased von Mises stress magnitude required to induce damage 
compared to controls.  Linear damage can reduce the biomechanical properties of bone 
and is traditionally associated with the terminal phase of bone fracture characterized by 
rapid crack propagation and catastrophic failure (Burr et al. 1998; Diab et al. 2005); thus, 
alendronate administration may predispose trabecular bone to the formation of more 
ominous microdamage patterns in the form of severe and linear microdamage. (Burr et al. 
1997; Burr et al. 1998; Diab et al. 2005) These observations may account for increased 
microcrack density in trabecular bone treated with alendronate for one year as more 
damage would form if the initiation threshold is lowered in this population. (Allen et al. 
2006) 
 Alendronate treatment has been shown to increase the thickness and 
mineralization of trabeculae, and this study corroborates that finding. (Recker et al. 2005) 
We found that thinner trabeculae with decreased mineral density and rod-like 
morphology are more likely to sustain severe damage in the treated samples compared to 
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non-treated controls.   The data suggest that the vulnerability of trabeculae to damage 
based on thinness is relative to the average trabecular thickness of the sample, for at the 
thickness of alendronate-treated severely damaged trabeculae, untreated trabeculae at the 
same thickness were undamaged.  There are two possible mechanisms to explain this 
finding: either there is a decrease in bone quality factors (tissue-matrix characteristics) in 
alendronate-treated trabeculae that promote damage formation, or architectural changes 
stemming from alendronate treatment expose the vulnerability of thinner trabeculae to 
damage.  Since trabecular stresses in severely damaged trabeculae were actually 
decreased compared to control samples, indicating that architectural changes do not place 
greater stresses on thinner trabeculae, this suggests that some other factor(s) related to 
bone quality facilitates severe damage formation in alendronate-treated bone.  
 It is well documented that due to the suppression of bone remodeling, alendronate 
increases tissue mineralization.  (Allen et al. 2006; Allen 2007)  When mineralization 
density was compared based on trabecular damage morphology, we found that 
mineralization was only increased in alendronate-treated samples which were diffusely 
damaged or undamaged.   Severely and linearly damaged trabeculae in alendronate-
treated samples were not differently mineralized compared to control trabeculae with the 
same damage morphology.  We have previously shown that microdamage initiation 
occurs around areas of decreased mineralization, and speculate that regions of low 
mineral/matrix ratio may result in greater local tissue compliance leading to damage 
initiation. (Nagaraja 2009)  This effect may be seen only at the 1 year stage of treatment 
as matrix mineral will continue to age and stiffen as bone turnover declines.  
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 Some aspects of the present study limit its broad applicability.  This study was 
conducted in bone from twelve animals, or four per treatment group.  This limits the 
power of the study to resolve stress differences due to treatment dose (1-β=0.49) or 
global architectural changes like bone volume fraction with alendronate treatment (1-
β=0.34).  Our stress analysis was conducted by analyzing almost 400 trabeculae, so we 
are more confident in the power of the study to resolve differences in the stress state due 
to damage morphology (1-β approaches 1).  Also, bone used for the microdamage 
analysis came from non-osteoporotic animals; thus, it is difficult to apply conclusions to 
osteoporotic humans using bisphosphonate therapies.  However, our study focused on 
changes in intrinsic level properties of trabecular bone elicited by alendronate use, and 
the bone physiology of humans and dogs is sufficiently similar to allow such 
investigations. (Aerssens et al. 1998; Shaw 2005)  Conclusions from this study are also 
limited by the assumption of linearity, homogeneity, and isotropy at the microstructural 
level, which somewhat limits the accuracy of the mechanical values obtained.  However, 
Nagaraja et.al. has shown that including inhomogeneous tissue moduli in finite element 
models offers only a modest improvement in the correlations between microdamage 
initiation and local stresses.  Furthermore, strong correlations between stress magnitudes 
and damage severity argue in favor of the finite element models’ accuracy in predicting 
tissue-level biomechanical properties. (Nagaraja et al. 2007)  Additionally, the 
conservative nature of the statistical tests used adds confidence to the conclusion that 
distinct differences in the state of stress of trabeculae bearing different microdamage to 
patterns exist.   
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 In conclusion, alendronate alters local mechanical and architectural properties of 
trabecular bone which may increase its susceptibility to damage after just one year of 
treatment. This study furthers our understanding of local tissue failure mechanisms, 
particularly in relation to the factors influencing damage morphology formation. The 
clinical implications of these findings are unclear since alendronate reduces fracture risk 





































THREE YEARS OF ALENDRONATE TREATMENT DOES NOT CONTINUE 
TO DECREASE MICROSTRUCTURAL STRESSES AND STRAINS 
ASSOCIATED WITH TRABECULAR MICRODAMAGE INITIATION  
 
6.1 Introduction 
 Bisphosphonates such as alendronate increase bone mass by reducing bone 
turnover, and clinical studies have demonstrated their efficacy at reducing osteoporotic 
fracture risk in areas with high levels of trabecular bone like the wrist, vertebral body, 
and proximal hip. (Black et al. 1996; Black et al. 2000; Rodan et al. 2002)  However, 
gains in bone strength and stiffness at the apparent level come at the expense of negative 
changes in the mineral and organic phases leading to a deterioration of the tissue-level 
material properties.  For instance, alendronate is associated with the gains in 
mineralization which contribute to improved bone strength and stiffness, but also leads to 
increases in non-enzymatic collagen crosslinking which can compromise bone toughness. 
(Allen 2007)  These changes may also cause an increased formation of microdamage, and 
reductions in bone turnover can allow such damage to accumulate. (Allen et al. 2006)  
Indeed, increased microdamage density has been documented after one year of treatment 
in animal studies. (Mashiba et al. 2000; Allen et al. 2006)  Microdamage accumulation 
itself can impact tissue-level material properties and may be a sign of decreased tissue 
quality. (Schaffler et al. 1989; Ruppel et al. 2006)   
Microdamage accumulation is not linear with increasing years of alendronate 
treatment.  Studies conducted in bisphosphonate-treated beagle dogs have shown that 
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microdamage density is increased relative to controls after one year of treatment, but has 
not continued to increase after three years of treatment.  (Allen et al. 2007)  There are 
many possible explanations for these findings: either continued gains in bone volume 
fraction and mineralization between 1 and 3 years’ treatment may improve the bone’s 
ability to resist damage formation, or a new equilibrium level for bone turnover may be 
sufficient to prevent further damage accumulation. (Allen et al. 2007)  Also, increased 
mineral homogeneity and reduced formation of new basic multicellular units (BMU) with 
prolonged treatment reduce stress concentrations which can serve as nucleation sites for 
damage formation. (Roschger et al. 2001; Boivin et al. 2002; Seeman 2007)   
In a recent study, increased microcrack density with alendronate treatment 
correlated with decreased tissue-level stresses associated with initiation of damage. 
(O'Neal et al. 2010)  It is unclear, however, whether such changes are sustained 
throughout the course of treatment.  In the present study, stresses and strains associated 
with microdamage formation were obtained using image-based finite element modeling 
of the distal femur from beagle dogs treated with three years of alendronate.  By 
investigating the response of alendronate-treated trabecular bone to damaging loads, 
microstructural changes that occur with prolonged treatment can be studied to determine 
factors which may contribute to the formation of microdamage.  The goal of this study 
was to determine whether tissue level stresses and strains associated with damage 
initiation changed throughout the course of alendronate treatment.  We hypothesize, 
based on observations of stabilized microdamage density between one and three years 
treatment, that damage initiation stresses and strains at three years’ treatment will not be 




 Detailed methods about the care and treatment regimen of animals whose tissues 
were used in this study have been published previously. (Allen et al. 2006)  Briefly, 1 
year old skeletally mature beagle dogs were randomized into three groups and given 
either a saline solution control (n=4, 1 mL/kg/day) or alendronate every day at either a 
post-menopausal osteoporosis treatment dose (n=4, 0.2 mg/kg/day), Paget’s disease 
treatment dose (n=4, 1.0 mg/kg/day) for three years.  All procedures were approved by 
the Indiana University School of Medicine Animal Care and Use Committee.  
6.2.2 Trabecular Bone Core Extraction and Micro-CT Imaging 
 The right distal femur from beagle dogs was secured using a vice such that the 
extraction angle was oriented parallel to the principal material axis.  Using a drill press 
with attached diamond-tipped core drill, 5 mm diameter bone cores were extracted under 
constant irrigation with saline. (#102055, Starlite Industries, USA)  Cores were sized to a 
length of 18 mm with a diamond precision saw, and bone marrow was removed using a 
water pik. (WP-72W, WaterPik, USA)  Stainless steel endcaps (5 mm depth) were glued 
with cyanoacrylate to each bone core end to prevent crushing and limit the effect of end 
artifacts on mechanical testing.  Cores were imaged with micro-computed tomography 
(µ-CT; µCT 40, Scanco Medical, Basserdorf, Switzerland) at a voxel resolution of 16 µm.  
Images were thresholded and evaluated to obtain parameters of bone volume fraction; 
trabecular thickness, number, and spacing; connectivity; structural model index; and 
degree of anisotropy.  Mineralization values were obtained from the attenuation of 
grayscale µ-CT images based on hydroxyapatite (HA) calibration standards.   
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6.2.3 Fluorescent Staining and Mechanical Testing 
 Trabecular bone cores were stained at atmospheric pressure and 4°C for 8 hours 
in 0.02% Alizarin ComplexOne + 10 µmol/L protease inhibitor (E-64, Sigma Chemical) 
then washed with distilled water for 1 hour to fluorescently label pre-existing damage, 
encompassing in vivo damage and damage occurring from the core extraction. (O'Brien et 
al. 2002) 
 Cores were preconditioned for 3 cycles to 0.1% strain then loaded at a rate of 
0.5% strain/second in displacement-controlled uniaxial compression to the yield strain, 
determined to be 1.2% in preliminary testing, and held for 3 hours.  The apparent strain 
was calculated using a gauge length of the exposed length of the bone measured with 
digital calipers plus half the length of each bone end embedded in endcaps. (Keaveny et 
al. 1997) During the test, cores were immersed in 0.9% physiological saline + 10 µmol/L 
protease inhibitor. 
 After testing, the top endcap was removed and cores were stained with 0.01% 
calcein at atmospheric pressure and 4°C for 8 hours then washed with distilled water for 
1 hour to label test-induced damage. (O'Brien et al. 2002)  Samples were held in 70% 
ethanol for 24 hours then underwent a graded alcohol infiltration protocol to completely 
dehydrate the samples.  Cores were embedded in methylmethacrylate, cut using a 
diamond precision saw to a thickness of 120 µm, and mounted onto slides in an 
orientation allowing for visual registration with the 3D micro-CT reconstructed image.  
6.2.4 Histological Evaluation  
 Microdamage was evaluated with fluorescent microscopy at 100x magnification 
based on the criteria that cracks are intermediate in size (20 – 150 µm; larger than 
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canaliculi but smaller than vascular channels), have sharp borders, and have a focus plane 
demonstrating depth of field. (Allen et al. 2006; Stepan et al. 2007)  A classification 
system published by Moore and Gibson was modified to group damage into three broad 
morphological categories: severe, linear, and diffuse damage. (Arthur Moore et al. 2002; 
O'Neal et al. 2010)   Severe damage was classified as microdamage consisting of either 
one primary crack with minor secondary cracks or cracks propagating through the 
thickness of the trabecula.  Linear damage included both single and parallel cracks, and 
diffuse damage consisted of both cross-hatch damage equal in length and intensity (to 
distinguish it from severe damage) and damage with a large area of distribution.  Areas of 
diffuse staining with no clearly defined cracks were not counted as microdamage.  
Investigators were blinded to the sample treatment group when conducting microdamage 
histological evaluations.   
6.2.5 Finite Element Analysis and Histological Registration 
 The 3D reconstructed micro-CT image of each trabecular bone core was used to 
create high resolution finite element models of von Mises and principal compressive 
stress and strain distributions.  Direct voxel conversion methods were used for mesh 
generation, and linear elastic, homogeneous, and isotropic material behavior was 
assumed. (van Rietbergen B 1996) Boundary conditions were set to simulate uniaxial 
compressive loading to the yield strain.  The tissue modulus for FEA was initially 
assigned to 10 GPa with a Poisson’s ratio of 0.3.   
 Test-induced microdamaged and undamaged trabeculae identified and categorized 
histologically were visually registered to its 3D micro-CT reconstructed image, allowing 
for digital extraction of the trabeculae of interest from the lattice.  A trabecular value for 
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the mechanical parameter associated with damage type was obtained by averaging the 
value of each element corresponding to the voxel within the extracted trabeculae.  Only 
green fluorescing (test-induced) damage and undamaged trabeculae underwent this 
analysis (n=416 for control, n=391 for low dose, n=346 for high dose).  Stress values 
were scaled according to the experimental Young’s modulus calculated from the stress-
strain curve during the mechanical test using a back-calculation method. (van Rietbergen 
B 1995) 
6.2.6 Statistics 
All statistical tests were performed using MINITAB software (Minitab, Minitab 
Inc., USA).  Parametric analyses were used for all comparisons after data met the 
requirement for normality.  Differences in global architectural parameters between 3 year 
treatment groups (Table 5.1) were determined with one-way ANOVA and Tukey post-
hoc tests.  Two-way ANOVA with Tukey post-hoc analysis was used to determine 
differences in global architectural parameters due to treatment group and treatment 
duration.  Differences in crack density were determined with two-way ANOVA followed 
by Tukey post-hoc analysis for treatment group and damage type comparisons.  p<0.05 
was considered statistically significant.  
To determine differences in mechanical and architectural parameters of damaged 
and undamaged trabeculae by treatment group and microdamage category, two-way 
ANOVA with Tukey post-hoc analysis was conducted.  Three-way ANOVA with Tukey 
post-hoc comparisons were conducted to assess statistical significance of the mechanical 
or architectural parameters with respect to damage state, treatment effect, and treatment 
duration.  A Bonferroni correction was applied for the 4 multiple comparisons made for 
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trabecular mechanical properties (von Mises and principal compressive stress and strain).  
The correction was also applied for the 4 multiple comparisons made in the trabecular 
architectural parameter analysis (trabecular thickness, structural model index, orientation, 
and mineralization).  This reduced the p value for a significant difference to p≤0.013. All 
data are presented as mean ± standard error. 
6.3 Results 
 Comparisons of global architectural properties across treatment groups show few 
differences between groups (Table 6.1).  Among the samples treated for 3 years with 
alendronate, the bone volume fraction was not different among the control and treatment 
groups.  Trabecular number, thickness, and spacing were also similar between groups.  
No differences were found in connectivity density, structural model index, or degree of 
anisotropy.  A specimen-specific tissue modulus was back-calculated from values of the 
experimental and FEM apparent moduli; tissue moduli for the control group were similar 
to the low dose group and high dose group. Average mineralization values were also 
similar between 3 years treated and control groups.  Between 1 and 3 years’ treatment, 
mineralization increased in control (1 year: 1011.9 ± 6.2 mg HA/ccm, 3 year: 1081.5 ± 
15.0 mg HA/ccm, p<0.005) and low dose treatment groups (1 year: 1040.3 ± 6.1 mg 









Table 6.1 Global Architectural Characteristics by Treatment Group 
12.2 ± 2.8 13.6 ± 2.811.5 ± 2.7 Tissue Modulus (GPa)
1077.3 ± 30.01091.1 ± 12.61081.5 ± 15.0 Mineralization (mg HA/ccm) 
1.51 ± 0.121.47 ± 0.041.49 ± 0.20Degree of Anisotropy (DA)
98.6 ± 8.6104.8 ± 17.8115.8 ± 17.5Trabecular Thickness (µm)
2.2 ± 0.12.2 ± 0.12.2 ± 0.1Trabecular Number (mm-1)
0.95 ± 0.581.2 ± 0.21.1 ± 0.7Structural Model Index (SMI)
22.5 ± 2.323.8 ± 2.620.8 ± 1.0Connectivity Density (mm-3)






 Severely damaged trabeculae were under greater von Mises stress than all other 
damage types within each treatment and control group (Figure 6.1, p<0.001).  In the low 
dose treatment group, diffusely damaged trabeculae were also under greater stress than 
linear and undamaged (p<0.001).  In the control group, diffusely damaged trabeculae 
were under greater stresses than undamaged trabeculae (p<0.001).   
Stress differences between treatment groups were also observed: in the low dose 
treatment group, the average von Mises stress associated with diffuse damage was 
significantly increased compared with control (Figure 6.1, p=0.002), and increased 
stresses in severely damaged trabeculae approached significance relative to controls as 
well. (p=0.02).  This reverses trends found in severely damaged trabeculae treated for 1 
year with alendronate, where von Mises stress values were significantly decreased 
compared with controls. (O’Neal et.al. 2010)  In this study, stress levels in the low dose 
group were also significantly greater than the high dose group in severely damaged 
trabeculae (p=0.006).  Similar results were seen in the analysis of principal compressive 
stress data except in the between group differences of the severely damaged trabeculae, 
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where stress comparisons approached, but did not achieve, significance (p=0.02 between 
low and high dose treatment; p=0.04 between low dose treatment and control).   
In comparing von Mises stress values between 1 and 3 year treatment groups, an 
increase in the stress value associated with severe damage in the low dose treatment 
group was the only significant change observed (p<0.001).  No differences in the 
principal compressive stresses associated with damage between 1 and 3 year treatment 




































Figure 6.1 Von Mises stress values by damage type and treatment group.  
Significantly increased stresses in severely damaged trabeculae relative to all other 
damage types were observed in each treatment group (*).  Stresses were also increased in 
severely damaged trabeculae in the low dose treatment group compared with those in the 
high dose treatment group.  Again in the low dose treatment group, stresses were 
increased in diffusely damaged trabeculae relative to controls. Bars represent significant 
differences, p<0.012; mean + SEM plotted 
 
 
 Strain states (both von Mises and principal compressive) were analyzed, and by 
both measures, severely damaged trabeculae were under significantly greater strain than 
all other damage types in the control and low dose treatment group at 3 years (Figure 6.2, 
p<0.001).  Severely damaged trabeculae were under greater strain than linear and 
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undamaged trabeculae in the high dose group (p<0.001).  Also, diffusely damaged 
trabeculae were under greater principal compressive strain than undamaged trabeculae in 
all treatment groups (p<0.01).  Finally in alendronate treated groups, diffusely damaged 
trabeculae were at higher strains than linearly damaged trabeculae (p<0.001).  No 
differences were found in the von Mises strain states of trabeculae between treatment 
groups.  Principal strain results, however, showed significantly increased strains in 
severely damaged trabeculae treated with low dose alendronate compared with the high 
dose treated group (p<0.01).  No differences in either strain measure were seen between 1 
and 3 years’ treatment. 
 
Figure 6.2 Principal compressive strain values by damage morphology and 
treatment group.  Significantly increased trabecular strains in severely damaged 
trabeculae were seen compared with all other damage types in the control and low dose 
treatment group (*) and in linearly damaged and undamaged trabeculae in the high dose 
treatment group.  Strains associated with severe damage were decreased in the high dose 
compared with low dose treatment group.  Diffusely damaged trabeculae were also under 
greater strain compared with linear and undamaged trabeculae in both treated groups, and 
undamaged trabeculae in the control group. p<0.012; bars indicate significant differences.  
Mean + SEM plotted. 
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Architectural characteristics of trabeculae undergoing mechanical parameter 
comparisons were determined from detailed morphometric analysis of the trabecula 
extracted from the 3D micro-CT reconstructed image.  Structural model index values 
showed that diffusely damaged trabeculae exhibited plate-like architecture compared 
with the more rod-like severe and undamaged trabeculae in treatment and control groups 
(p<0.01).  In the treated groups, severely damaged trabeculae were more rod-like than 
diffusely damaged trabeculae (p<0.01).  When trabecular thickness was analyzed, it was 
apparent that thinner trabeculae were more likely to sustain severe damage than remain 
undamaged, regardless of treatment or control group (p<0.01).  Trabecular mineralization 
was greater in the severely damaged, low dose treatment group compared with controls 
and the high dose treatment group; in controls, severely damaged trabeculae were less 
mineralized than undamaged.  No association with trabecular orientation was noted in 

















































































































Figure 6.3 Architectural characteristics of trabeculae by damage type and treatment 
group.  6.3a. Characterization of the structural model index of damaged trabeculae 
showed rod-like architecture of severe and undamaged trabeculae relative to diffusely 
damaged trabeculae in all treatment groups.  6.3b. Severely damaged trabeculae were 
thinner than undamaged trabeculae in all treatment groups.  6.3c. Evaluation of the 
trabecular orientation relative to the loading axis did not show differences in the 
formation of damage of different morphologies.  6.3d. Severely damaged trabeculae in 
the low dose treatment group were significantly more mineralized than severely damaged 
trabeculae in the low dose and control groups.  p<0.012, bars represent significant 
differences; mean ± SEM plotted. 
  
Histological analysis of pre-existing (alizarin-labeled) damage showed primarily 
linear damage, with an increased linear damage density in the high dose treatment group 
(1.03 ± 0.14 incidents/mm2) compared with low dose (0.45 ± 0.05 incidents/mm2) and 
control group (0.47 ± 0.08 incidents/mm2, p<0.01).  Test-induced (calcein-labeled) 
damage density was significantly increased compared with pre-existing damage density 
in each treatment and control group. (Figure 6.4, p<0.05)  Damage exhibiting both the 
alizarin and calcein stain was totaled separately, and no differences were found between 
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treatment or control groups.  Damage totals (the sum of pre-existing, test-induced, and 
dual-stained damage) were not significantly different between treatment or control 



































Figure 6.4  Damage quantification totals by treatment group.  There was significantly 
increased test-induced damage compared with pre-existing damage in each treatment 
group.  Also, there was a larger amount of test-induced damage than damage 
demonstrating dual fluorescence in the control group. p<0.05, bars indicate significant 




 In this study, the effect of prolonged daily alendronate treatment on trabecular 
stresses and strains associated with microdamage initiation were investigated using 
image-based finite element modeling.  It was found, compared with controls, that in the 
low dose alendronate treatment group the principal compressive and von Mises stresses 
were increased significantly in diffusely damaged trabeculae (p<0.01), and approached 
significance in severely damaged trabeculae (p=0.02) compared with controls.  This 
finding reverses a trend observed in a similar study conducted after 1 year of treatment at 
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the same doses, where von Mises stresses of severely and linearly damaged trabeculae 
were significantly decreased in alendronate-treated groups compared with controls. 
(O'Neal et al. 2010)  These results suggest that while alendronate may initially reduce the 
ability of trabecular bone to resist damage formation, by 3 years of treatment the tissue 
level properties have stabilized.  
 Image-based finite element modeling is a powerful tool which can be used to 
integrate the contributions of trabecular geometry, material property, and spatial position 
to capture the loading environment of a single trabecula.  It is advantageous in small, 
complex systems because of the difficulty in obtaining individual trabecular stresses and 
strains from direct measurement.  Stresses obtained from FEM were linearly scaled to 
reflect specimen-specific differences in stiffness calculated from the linear elastic region 
of the apparent level stress-strain curve.  (van Rietbergen B 1995)  This method ensures 
that average tissue-level stresses between groups are similar despite differences in bone 
volume fraction and mineralization which influence the mechanical strength and 
maximum applied load.   
Previous studies have used the von Mises yield criterion to describe the 
micromechanical environment of trabecular bone. (Fyhrie et al. 2000; Yeni et al. 2008)  
The von Mises yield criterion is useful in this context because it accounts for the 
contribution of normal and shear stresses/strains to characterize the loading environment 
of trabeculae.  Particularly for damage exhibiting severe or cross-hatched morphology, it 
is clear that shear forces play an important role in damage evolution. (Fyhrie et al. 2000)  
Principal compressive stresses/strains have also been used to characterize microstructural 
damage mechanics, and as previous studies correlating these measures to microdamage 
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incidents have failed to produce a dominant criterion, results from all of these measures 
are reported. (Nagaraja et al. 2005)   
Overall, trabecular level stresses and strains remained relatively constant between 
1 and 3 years in all treatment and control groups.  An increase in the von Mises stress 
value associated with severe damage in the low dose treatment group was the only 
treatment durational difference noted.  Thus, the extension of alendronate treatment to 3 
years does not continue to decrease damage initiation stresses relative to controls, as seen 
after 1 year of treatment.  Rather, the susceptibility of trabecular bone to microdamage 
formation appears to stabilize, and data on microdamage quantification reported in this 
study and others corroborate this conclusion. (Allen et al. 2007)  We hesitate to conclude 
that bone quality is improved overall with prolonged alendronate treatment because other 
studies have documented decreased toughness in alendronate treated bone, but did not 
attribute such findings to microdamage formation. (Allen et al. 2007; Allen et al. 2008)  
Rather, findings from this study help elucidate the complexities of the mechanical 
changes leading to reduced microdamage formation at the tissue level.   
In this study, we observed a significantly increased mineral density in severely 
damaged trabeculae from the low dose treatment group compared with severely damaged 
trabeculae in the high dose treatment group and controls (Figure 6.3).  Furthermore, the 
mineral density was significantly increased in the severely damaged trabeculae at 3 years’ 
low dose alendronate compared to values after 1 year of treatment at the same dose 
(p<0.001).  (O'Neal et al. 2010)  Though our finite element models were homogenous and 
did not account for local stiffness differences in stress calculations, values for 
microstructural stresses were scaled according to the stiffness at the apparent level, 
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resulting in an 11% increase in the back-calculated tissue modulus between 1 and 3 years 
in the low dose treatment group.  We speculate that changes in the mineralization profile 
at the microstructural level may contribute to increased resistance to damage initiation.  
Since bone turnover is suppressed with alendronate, secondary mineralization is more 
complete in bone multicellular units (BMU) and may provide additional strength against 
damaging forces. (Boivin et al. 2002)  However, additional analyses with inhomogeneous 
models are warranted to confirm this hypothesis.  
 Evaluation of the architectural characteristics within damage morphological 
groups revealed few differences between treatment and control groups and few changes 
from one to three years.  Decreased trabecular thickness and rod-like geometry were 
associated with severe damage formation in this study, and the observation has been 
made by others in different populations. (Shi et al. ; Arlot et al. 2008)  This suggests that 
the influence of trabecular geometry on damage susceptibility remains fairly consistent. 
 A number of limitations must be considered when placing the results of this study 
in the context of fracture risk with prolonged alendronate treatment.  The use of intact 
(non-ovariectomized), relatively young beagle dogs limits the translation of this study’s 
findings to osteoporotic human populations, and the small number of samples in each 
group may not capture the full variability of trabecular bone architecture in the 
population.  Additionally, while the assumptions of linear elasticity, isotropy, and 
homogeneity at the microstructural level provide a good estimate of tissue level 
mechanical properties, they are not completely accurate in describing tissue-level 
trabecular behavior, particularly when used to understand evolving properties in the face 
of microdamage progression.  For this reason, it should be understood that stress/strain 
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calculations refer only to predictions from the undamaged state, and do not account for 
changes which may occur once the damage initiation process has begun.  However, this 
study illuminates the microstructural mechanics associated with microdamage formation 
and sheds some light on the effect of alendronate administration on those mechanisms. 
 In this study, tissue-level stresses and strains from alendronate-treated trabecular 
bone were computed with FEM, registered with histological observations of 
microdamage incidents, and compared to control groups and stress/strain levels obtained 
after 1 year of treatment.  We conclude that changes in damage initiation stresses/strains 
occur early in treatment (within the first year) and do not continue to deteriorate with 
alendronate treatment up to 3 years.  We speculate that improvements in the 



























CONCLUSIONS AND FUTURE RECOMMENDATIONS 
 
7.1 Conclusions 
 Bone fractures in the elderly are more likely to lead to life-threatening health 
complications than those in younger populations, not only decreasing their quality of life, 
but also straining the health care industry with the burden of providing long term care and 
support for these patients.  The elderly population is expected to represent 20% of the US 
population in 2030, (AOA 2006) highlighting the great need for research that can lead to 
the prevention of non-traumatic bone injury.   
Bone fragility fractures are most prevalent in areas with a high proportion of 
trabecular bone like the hip, wrist, and vertebrae.  A significant factor in the development 
of such fractures is osteopenia, or low bone mass, but it is not the only factor. 
(McCreadie et al. 2000)  Other factors influencing trabecular bone fragility are numerous: 
structural changes in bone volume fraction, connectivity, trabecular number, thickness, 
spacing, and anisotropy; compositional changes in mineralization, collagen crosslinking, 
and accumulation of AGEs; and changes in mechanical adaptation, including 
microdamage formation and repair. (Schaffler et al. 1989; Burr et al. 1997; Hildebrand et 
al. 1999; Yeh et al. 2001; Paschalis et al. 2004; Busse et al. 2009)  Microdamage density 
in particular can be an independent predictor of bone strength. (Burr et al. 1997)  In the 
preceding chapters, factors influencing microdamage initiation and progression were 
explored as a function of age, sex, and the use of therapeutics designed to limit the 
osteoporotic loss of bone mass.  The goal of this work was to demonstrate that changes in 
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trabecular bone quality due to these influences are reflected in the mechanics of 
microdamage initiation and propagation. 
 In chapter 3, a powerful technique combining finite element modeling with 3D 
reconstructed micro-CT images of trabecular bone was used to obtain estimations of 
stresses and strains on individual damaged trabeculae from three groups:  younger 
women, older women, and older men.  Results suggest that microdamage morphology is 
highly dependent on both the stress and strain magnitude, and that trabecular bone from 
pre-menopausal women may be able to sustain higher stresses/strains without damaging 
compared with trabecular bone from post-menopausal individuals.  However, the 
response to damaging loads appears similar between men and women aged 68-81 years, 
though severely damaged trabeculae in men underwent less deformation than severely 
damaged trabeculae in women.  In chapter 4, we describe a two-step mechanical loading 
process used to induce and propagate microdamage, and explored aging and gender 
differences in their resistance to microdamage progression.  We found that samples from 
older donors reached the fatigue test endpoint with a fewer number of cycles than 
younger individuals, and attributed this result to an increased number of severe damage 
incidents which were expanding in area.  However, no gender differences were found.  
Finally in chapters 5 and 6, microstructural stresses and strains associated with 
microdamage initiation were investigated in trabecular bone from dogs treated for 1 or 3 
years with alendronate.  After one year of alendronate administration, tissue level 
biomechanical properties of trabecular bone are altered, resulting in a decreased von 
Mises stress necessary for initiation of severe and linear microdamage.  By three years of 
treatment, however, damage initiation stresses and strains had stabilized.  
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7.2 Future Recommendations: Microdamage Initiation Stress Differences               
by Age and Gender 
 In this study, the stresses and strains of individual trabeculae were obtained from 
finite element solutions visually registered with histological identification of 
microdamage of different morphologies.  Results were compared between younger and 
older females, and between older males and older females.  We found that trabecular 
stresses in undamaged trabeculae of older women were lower compared to younger 
women, suggesting that the threshold for damage initiation may decrease with increasing 
age.  Also, normalized strains associated with severely damaged trabeculae in men were 
significantly reduced compared to age-matched women.   
 Although the stress and strain estimations were matched to trabecular damage 
created experimentally under known loading conditions, models used trabecular bone 
structures in their undamaged state for the calculations.  Changes in the stress/strain 
values with damage formation and propagation were not captured with this technique.  
Damage formation has been shown to dissipate energy, thereby relieving stresses on 
nearby trabeculae and increasing the fracture toughness of the bone. (Vashishth et al. 
1997)  In order to gain a full understanding of the role of trabecular damage in the 
energy-absorbing function of trabecular bone, non-linear finite element modeling should 
be utilized.  Until very recently, the use of complex models on structures with a very 
large number of elements has been too computationally expensive to execute.  With 
advances in computing power, however, it is now possible to conduct non-linear finite 
element analyses on trabecular bone structures that meet the requirements for continuum 
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assumptions. (Kosmopoulos et al. 2008)  Further refinement of techniques used in this 
study can give new insight into damage mechanics of trabeculae.  
 The correlation of von Mises and principal compressive stresses and strains with 
damage morphology produced good results consistent with our understanding of 
interactions between the magnitude of loading and damage formation.  However, these 
criteria were developed for yield prediction in materials with similar tensile and 
compressive strengths.  Studies in bone have demonstrated asymmetry in apparent 
behavior; specifically, greater strength in compression than tension. (Niebur et al. 2001)  
Furthermore, at the microstructural level, differences in the morphology and behavior of 
damage based on whether loading is predominantly in tension or compression have been 
described. (Diab et al. 2005)  Therefore, use of asymmetric yield criteria may improve 
damage predictions and more accurately represent yielding behavior.  (Niebur et al. 2000; 
Bayraktar et al. 2004) 
 Throughout this thesis, damage has been classified into categories based on 
morphology, severe, diffuse, and linear, which were derived from a previously published 
classification system. (Arthur Moore et al. 2002)  However, much debate centers on the 
driving mechanisms behind the assumed morphology.  Results in this thesis suggest that 
crack morphology is driven greatly by the magnitude of stresses and strains placed on the 
trabeculae, but others have shown a dependence of crack morphology on a tensile versus 
compressive loading environment. (Diab et al. 2005)  The methods described in chapter 
3, 5, and 6 can be used to spatially correlate damage regions with tensile or compressive 
loading derived from the directions of principal compressive stresses and/or strains 
obtained with finite element modeling.  Furthermore, correlations between observed 
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damage regions of specific morphologies and goodness-of-fit predictions by different 
yield criteria can provide additional data about the mode of loading.   
 Statistical models used throughout this thesis were built using parametric and 
non-parametric methods which evaluated mean/median differences between groups to 
determine statistical significance.  However, particularly for research involving 
prediction and risk assessment in human disease, Bayesian statistical methods may be of 
more utility.  Bayesian methods incorporate pre-existing knowledge about the 
relationship between two variables with new evidence to provide more precise 
conclusions.  They are especially useful in hierarchical models, as used throughout this 
thesis, and provide a way to pool data from different data sets in order to evaluate 
relationships between parameters more fully.  Future studies can apply Bayesian models 
to new data sets to evaluate significant differences in the context of pre-existing data 
regarding the relationship between two parameters.  This approach help elucidate global 
patterns of architectural and mechanical parameters’ effects on damage initiation as a 
function of differences in age and gender.    
 Currently, experiments dependent upon user-driven identification and 
classification of microdamage are limited by the enormous amount of time required for 
in-depth analysis.  As a result, sample sizes reported in microdamage comparison studies 
are relatively small.  Development of an automated identification system based on 
damage fluorescent staining intensity was developed in this lab; however, results were 
complicated by non-specific staining and the inability to obtain information regarding 
damage morphology. (Nagaraja 2006)  Future studies focused on automating 
microdamage analyses would greatly expand the potential for future experiments to 
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capture population variability.  Some studies are currently underway towards achieving 
that goal. (Bigley et al. 2008) 
 Alternatively, the use of radiopaque dyes to identify microcracks in bone 
structures would allow for the use of micro-CT systems to image the character and 
distribution of damage.  Such a dye would be extremely valuable to microdamage 
research, not only in identifying damage, but also in generating finite element models 
which incorporate damage sites in their analyses.  Some research towards this end has 
already been conducted, particularly with the use of barium sulfate. (Leng et al. 2008; 
Landrigan et al. 2011)  While barium sulfate has shown some promise as a radiopaque 
dye in bone, its primary mechanism of action is space-filling rather than targeted.  Future 
studies could focus on developing dyes with greater specificity, exploiting the availability 
of calcium-binding sites in damage similar to the mechanism of action of the calcium-
chelating fluorescent dyes used in this study. (O'Brien et al. 2002)   
7.3 Future Recommendations: Resistance to Microdamage Progression                   
by Age and Gender 
 In this study, differences in microdamage progression were investigated between 
younger females, older females, younger males, and older males.  A decreased number of 
cycles to the strain endpoint were found in older samples, reflecting decreased tissue 
resistance to microdamage progression.  Histological observations of microdamage at the 
trabecular level offered clues towards an explanation for this finding.  Specifically among 
severely damaged trabeculae, the damage area was greater in bone from younger 
individuals, while the number of trabeculae whose damage area was increasing was 
greater in older individuals.  This suggests that in trabecular bone, the damage area of a 
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single trabecula is not as important to the fatigue life of the entire sample as is the 
number of damage incidents, as the damage remains localized and can be removed. 
(Cook et al. 2009)   
 While results from this study are compelling, further investigations into the 
factors causing age-related differences in crack growth resistance should be undertaken.  
Specifically, combining histological damage quantification with non-linear finite element 
modeling to determine microstructural stresses and strains associated with crack 
progression can add much to the understanding of trabecular bone mechanics.  Very few 
modeling studies of fatigue using trabecular bone structures have been completed, but 
recent work by Kosmopoulos et al verified hypotheses determined using idealized 
cellular solids about the role of trabecular failure in overt fracture. (Kosmopoulos et al. 
2008)  Expanding the use of these techniques can add to the understanding of how forces 
are redistributed with additional loading cycles within a trabecular bone lattice.  
One limitation of this study was the inability to capture microdamage progression 
patterns during the fatigue portion of mechanical testing.  Though the measurements of 
crack density and area expansion before and after the test were illuminating, it is 
unknown which damage areas contributed towards the initial sharp increases in strain and 
which areas contributed to the slowly increasing strain towards failure.  Though use of 
additional fluorescent dyes could be used to obtain a snapshot of fatigue mechanisms 
during the test, (O'Brien et al. 2002) we were unable to differentiate between three or 
more applied stains.  Recently, high speed photography was used to image damage areas 
under compression loading as damage was forming. (Thurner 2006; Thurner 2007)  
Using a similar method, future studies could capture microdamage progression in cyclic 
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loading to address unanswered questions regarding damage localization and 
compartmentalization.  
  In this study, we associated the decreased number of cycles found in older donors 
with an increased number of trabeculae whose damage area was increasing.  In younger 
samples, however, extensive damage area of trabeculae did not appear to hasten overt 
trabecular failure.  It has been suggested that this behavior is analogous to a crumple zone 
in cars, where sacrificial elements allow energy to be dissipated in order to preserve the 
integrity of other nearby structures. (Badiei et al. 2007; Cook et al. 2009)  Finite element 
models of idealized cellular solids have shown that while isolated areas of failed 
structures may indeed have this effect, damaged structures inevitably congregate and lead 
to the failure of the entire structure. (Guo et al. 1994)  It is unclear whether a loading 
situation would arise in vivo which would call this mechanism into play, but future 
studies could be undertaken to address this apparent paradox in the fatigue behavior of 
trabecular bone.  
7.4 Future Recommendations: The Effect of Alendronate Treatment on  
Microdamage Initiation  
 In this study, the microstructural stresses and strains associated with microdamage 
formation were obtained using image-based finite element modeling of the distal femur 
from beagle dogs treated for one or three years with alendronate.  It was found that with 
alendronate treatment at low doses, stresses were increased significantly in diffusely 
damaged trabeculae and approached significance in severely damaged trabeculae 
compared with controls.  These results reverse findings after one year of low-dose 
alendronate treatment, where von Mises stresses of severely and linearly damaged 
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trabeculae were significantly decreased compared with controls.  These results suggest 
that while alendronate may initially reduce the ability of trabecular bone to resist damage 
formation, by 3 years of treatment the tissue level properties have stabilized.  
 The results in this study are compelling; however, they were conducted in 
trabecular bone of the distal femur, and conclusions may not translate to different parts of 
the skeleton.  It is known that bisphosphonates accumulate in greater concentrations in 
bone undergoing constant remodeling, such as the jaw and sites with trabecular bone. 
(Rodan et al. 2002)   Thus, it seems reasonable that the effects of alendronate treatment 
may be unevenly distributed throughout the skeleton.  Studies similar to those detailed in 
chapters 5 and 6 can be done to determine the effect of alendronate on microstructural 
properties in different skeletal sites.   
Additionally, in chapters 5 and 6, microdamage initiation thresholds were studied 
after the application of a single static load to yield.  Though the mechanics of 
microdamage initiation are an important indication of bone quality, resistance to 
microdamage progression is also an important factor in evaluating the microstructural 
properties of bone.  Very few studies have investigated how crack propagation 
mechanisms in bone treated with bisphosphonates may differ from untreated bone.  
Evidence that changes occurring at the ultrastructural level, particularly in the degree of 
glycation of the tissue, can increase tissue brittleness and reduce toughness.  (Allen 2007; 
Tang et al. 2009)  Conducting studies similar to those performed in chapter 4 coupled 
with analysis of compositional changes in the tissue matrix could add additional insight 
into the effects of alendronate treatment on microstructural properties of bone.   
Recently, concerns about the effects of long-term remodeling suppression on 
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bone’s mechanical properties have been corroborated by reports of an increased 
microdamage density with treatment. (Allen et al. 2006)   Two iliac crest bone biopsy 
studies conducted in human tissue found conflicting results regarding increased crack 
density with alendronate use. (Chapurlat et al. 2007; Stepan et al. 2007)  Since 
microdamage accumulation is linked to decreased bone strength and stiffness, (Burr et al. 
1997; Hoshaw et al. 1997) more studies need to be done in human subjects to determine 
definitively whether a link between bisphosphonate use and microdamage accumulation 
exists, and whether there are clinical implications for such findings.    
Case reports describing atypical fractures of the femoral diaphysis in women 
taking bisphosphonates have led to questions about the long-term safety of these 
therapeutics. (Osugi et al. 2011)  Currently, little data exists which directly link 
bisphosphonate use with atypical fracture; however, the rarity of such fractures makes it 
difficult to design studies investigating possible associations. (Neviaser et al. 2008; Black 
et al. 2010)  Nonetheless, lingering doubts have led physicians to consider drug holidays 
for patients taking bisphosphonates for an extended period of time (>5 years).  (Shane 
2010)  A recent study investigating the implications of a drug holiday after 2 years of 
treatment on fracture risk found an increased incidence of hip fractures in women who 
discontinued the drug, but more data are needed to address this issue. (Curtis et al. 2008)  
Future studies should be undertaken that investigate the consequences of discontinuing 
bisphosphonates after 5 years of treatment, and determine how long drug holidays should 
last before fracture risk increases. 
7.5 Concluding Remarks 
In this thesis, we have explored factors influencing microdamage initiation and 
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propagation in two conditions relevant to clinical health: aging and bisphosphonate use.  
We have demonstrated that, through the combined use of fluorescent microscopy, micro-
CT, and finite element modeling, microstructural bone quality can be represented by 
alterations in bone’s ability to resist the formation and propagation of microdamage.  
With this technique, we have demonstrated that the changes in trabecular bone that occur 
with aging may result in a reduced ability to resist microdamage formation and 
propagation.  Furthermore, we showed that 1 year of alendronate use may reduce the 
ability of trabecular bone to resist microdamage formation resulting in an increased 
microcrack density, but that by 3 years of treatment, the microstructural properties have 
recovered.  Results from this thesis may be used in future investigations into the 
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